Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E21.47 EPS (ttm)1.53 Insider Own0.50% Shs Outstand2.53B Perf Week0.58%
Market Cap83.07B Forward P/E19.44 EPS next Y1.69 Insider Trans0.00% Shs Float2.50B Perf Month12.87%
Income3.87B PEG2.90 EPS next Q0.55 Inst Own15.00% Short Float0.57% Perf Quarter-7.21%
Sales21.74B P/S3.82 EPS this Y23.80% Inst Trans0.83% Short Ratio2.73 Perf Half Y4.82%
Book/sh5.39 P/B6.09 EPS next Y-10.97% ROA6.10% Target Price34.89 Perf Year-2.79%
Cash/sh2.46 P/C13.32 EPS next 5Y7.40% ROE28.40% 52W Range25.55 - 35.60 Perf YTD20.10%
Dividend0.90 P/FCF- EPS past 5Y-17.60% ROI15.00% 52W High-4.63% Beta0.72
Dividend %2.74% Quick Ratio0.70 Sales past 5Y-7.30% Gross Margin82.90% 52W Low32.88% ATR0.44
Employees59700 Current Ratio0.90 Sales Q/Q-9.90% Oper. Margin24.90% RSI (14)68.03 Volatility0.77% 1.14%
OptionableYes Debt/Eq1.44 EPS Q/Q- Profit Margin17.80% Rel Volume1.95 Prev Close32.81
ShortableYes LT Debt/Eq1.23 EarningsOct 26 BMO Payout117.70% Avg Volume5.25M Price33.95
Recom1.80 SMA208.40% SMA509.32% SMA20010.64% Volume10,233,431 Change3.47%
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Apr-05-17Downgrade UBS Buy → Neutral
Mar-09-17Initiated Liberum Buy
Dec-09-16Upgrade Leerink Partners Mkt Perform → Outperform
Nov-25-16Upgrade Liberum Hold → Buy
Sep-23-16Initiated Piper Jaffray Overweight
Sep-12-16Upgrade Jefferies Hold → Buy
Aug-29-16Upgrade Argus Hold → Buy
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Sep-22-17 01:08PM  AstraZeneca Stock Upgraded: What You Need to Know Motley Fool
12:56PM  [$$] AstraZeneca climbs as Bernstein backs takeover talk Financial Times
Sep-20-17 09:00AM  Implied Volatility Surging for AstraZeneca (AZN) Stock Options Zacks
Sep-19-17 03:30AM  3 High-Yield Pharmaceutical Stocks Motley Fool
Sep-15-17 10:55AM  Oncology Space in Focus this Week on ESMO Presentations Zacks
Sep-14-17 12:38PM  Bydureon EXSCEL Trial Demonstrates Favorable Cardiovascular (CV) Safety Profile and Fewer CV Events in Patients with Type-2 Diabetes at Wide Range of CV Risk Business Wire
11:12AM  AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs Zacks
07:54AM  [$$] Moderna Therapeutics raises hopes for drug after human trials Financial Times
07:00AM  Moderna, AstraZeneca heart drug succeeds early-stage trial Reuters
03:30AM  Astra's Farxiga results may open up type 1 diabetes opportunity Reuters
Sep-12-17 05:36PM  Bristol-Myers Reports Positive Results from Melanoma Study Zacks
11:25AM  AstraZeneca's Asthma Candidate Shows Promising Results Zacks
Sep-11-17 03:30PM  Regeneron: When Good Isn't Good Enough Barrons.com
03:17PM  AstraZeneca's Lung Cancer Study Data Promising, Shares Spike Zacks
12:12PM  U.K. stocks edge higher as fears over Irma, North Korea ease MarketWatch
11:21AM  [$$] Teva poaches chief from Danish drugmaker Lundbeck Financial Times
10:42AM  AstraZeneca Wins in Cancer by Going Its Own Way Bloomberg
10:21AM  [$$] AstraZeneca, Merck and Inctye boosted by cancer treatment advances Financial Times
05:47AM  AstraZeneca Spikes After Lung Cancer Treat Study Shows 'Encouraging' Results TheStreet.com
05:32AM  Cancer immunotherapy proves itself in earlier-stage disease Reuters
02:10AM  AstraZeneca rebuilds cancer drug hopes with new lung data Reuters
Sep-09-17 11:04AM  AstraZeneca CEO, worried by Brexit, not signing UK government letter Reuters
04:30AM  AstraZeneca rebuilds cancer drug hopes with new lung data Reuters
Sep-08-17 06:46PM  AstraZeneca shares tick higher on lung cancer drug study results MarketWatch
06:24PM  AstraZenecas TAGRISSO® (osimertinib) Shows Potential as a New Standard of Care in 1st-Line EGFR-Mutated Non-Small Cell Lung Cancer at ESMO 2017 Congress Business Wire
06:24PM  AstraZeneca Presents Superior Progression-Free Survival for IMFINZI® (durvalumab) in the Pacific Trial of Patients with Locally-Advanced Unresectable Lung Cancer at ESMO 2017 Congress Business Wire
06:07PM  [$$] AstraZeneca looks for boost from positive trials Financial Times
06:05PM  AstraZeneca rebuilds cancer drug hopes with new lung data Reuters
10:10AM  Company News For Sep 8, 2017 Zacks
08:52AM  AstraZeneca (AZN) Looks Good: Stock Adds 5.1% in Session Zacks
08:10AM  Today's Research Reports on Trending Tickers: AstraZeneca and NewLink Genetics ACCESSWIRE
Sep-07-17 01:28PM  [$$] Hopes for cancer treatment buoy AstraZeneca Financial Times +5.11%
11:06AM  Amgen/AstraZeneca Asthma Candidate Tezepelumab Shows Promise Zacks
10:52AM  Why Regeneron Is Getting Smoked Barrons.com
10:32AM  Merck (MRK) Opts for Buying German Immuno-Oncology Biotech Zacks
10:18AM  AstraZeneca's COPD Candidate Duaklir Reports Positive Data Zacks
08:01AM  FDA puts Celgene's multiple cancer trials on hold Reuters
05:29AM  New AstraZeneca, Amgen drug looks strong rival in severe asthma Reuters
02:48AM  Positive lung drug trial opens path to U.S. market for Circassia Reuters
Sep-06-17 05:07PM  Tezepelumab Significantly Reduced Asthma Exacerbations For A Broad Population Of Patients With Severe Uncontrolled Asthma PR Newswire
05:00PM  New AstraZeneca, Amgen biotech drug offers broad asthma relief Reuters
09:06AM  Performance of AstraZenecas Other Products in 2Q17 Market Realist
07:36AM  Performance of AstraZenecas Oncology Segment in 2Q17 Market Realist
Sep-05-17 03:30PM  Lannett receives FDA OK for generic Nexium product American City Business Journals
10:37AM  AstraZeneca Chief Soriot Says He's Worried About Brexit Talks Bloomberg
10:36AM  Performance of AstraZenecas Respiratory Segment in 2Q17 Market Realist
09:07AM  Performance of AstraZenecas CVMD Segment in 2Q17 Market Realist
07:37AM  Performance of AstraZenecas Growth Platforms in 2Q17 Market Realist
Sep-04-17 10:37AM  AstraZenecas Segment-Wise Performance in 2Q17 Market Realist
09:07AM  Chart in Focus: AstraZenecas Revenues in 2Q17 Market Realist
07:38AM  Changes in AstraZenecas Valuation after Its 2Q17 Earnings Market Realist
Sep-01-17 03:43PM  Parkinson's Now a Hot Therapeutic Area: What's Up Lately? Zacks
Aug-31-17 08:48AM  AstraZeneca aims to offset drug setback at big cancer congress Reuters
08:02AM  AstraZeneca's M&A Daydreams Bloomberg
Aug-30-17 01:55PM  [$$] AstraZeneca sinks after Goldman urges caution Financial Times
11:44AM  AstraZeneca and Takeda Ink Deal to Develop Parkinson's Drug Zacks
10:30AM  Company News for August 30, 2017 Zacks
Aug-28-17 10:01AM  [$$] AstraZeneca uses AI to tackle neurological disease Financial Times
10:00AM  AstraZeneca taps AI for drug discovery in deal with Berg Reuters
07:00AM  FASLODEX® (fulvestrant) Receives US FDA Approval as Monotherapy for Expanded Use in HR+, HER2- Advanced Breast Cancer Business Wire
06:57AM  Novo Nordisk's Victoza Gets FDA Nod for Label Expansion Zacks
06:56AM  AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting Zacks
06:00AM  3 High-Yield International Stocks Motley Fool
Aug-27-17 06:29PM  [$$] AstraZeneca to announce plans for UK investment Financial Times
Aug-25-17 12:08PM  Better Buy: Inovio Pharmaceuticals, Inc. vs. Novavax, Inc. Motley Fool
07:22AM  Pharma Stock Roundup: Roche Drug Gets Priority Review, EU Nod for Novartis Drug Zacks
Aug-22-17 06:05PM  Perrigo's (PRGO) OTC Version of Nexium Secures FDA Approval Zacks
07:23AM  3 Most Promising Cancer Drugs in Late-Stage Development Motley Fool
Aug-21-17 07:35PM  [$$] German Biotech Startup Ethris Strikes Respiratory Drug Deal With AstraZeneca The Wall Street Journal
08:50AM  Champions Oncology shares surge 8% on news of AstraZeneca collaboration MarketWatch
Aug-18-17 06:33PM  Tesaro: Losing Its Edge? Barrons.com
04:27PM  Ovarian Cancer Market Still Up For Grabs Barrons.com
10:01AM  AstraZeneca/Merck's Lynparza Gets FDA Nod for Label Expansion Zacks
Aug-17-17 05:23PM  FDA expands use of AstraZeneca/Merck ovarian cancer drug Reuters
04:35PM  FDA approves expanded use of AstraZeneca ovarian cancer drug Reuters
04:22PM  LYNPARZA® (olaparib) Receives Additional FDA Approval in the US for Ovarian Cancer Business Wire
Aug-16-17 01:23PM  AstraZeneca Plc : AZN-US: Dividend Analysis : August 11th, 2017 (record date) : By the numbers : August 16, 2017 Capital Cube
Aug-15-17 04:55AM  Shire Gains as it Seeks European Approval For Dry Eye Treatment TheStreet.com
Aug-14-17 04:10PM  ETFs with exposure to AstraZeneca Plc : August 14, 2017 Capital Cube
03:42PM  Big-name U.S. hedge funds shed healthcare stocks during the rally in Q2 Reuters
Aug-09-17 09:02AM  Biotech: Why Clovis And Tesaro Look Well Positioned Barrons.com
Aug-08-17 02:36PM  A Biotech Binary Event Playbook: How To Play Clovis And Tesaro Ahead Of Label Decision Benzinga
12:00AM  Brexit Is Quietly Killing Science Bloomberg
Aug-07-17 04:39PM  Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Intrepid Potash, Inc. (IPI) and Marathon Oil Corporation (MRO) Are 3 of Todays Worst Stocks InvestorPlace
02:15PM  3 High-Yield Stocks for Aggressive Investors Motley Fool
12:01AM  AstraZeneca Takes a Long Shot on Lung Cancer Drug Study Bloomberg
Aug-04-17 05:51PM  Here's Why Agenus Inc. Stock Slipped 13.6% in July Motley Fool
10:00AM  Why AstraZeneca plc Stock Broke Down in July Motley Fool
08:47AM  Pharma Stock Roundup: Mixed 2Q Results from Pfizer, Bristol-Myers Announces IO Deals Zacks
08:05AM  [$$] AstraZeneca is beginning to look a lot like Tesco Financial Times
Aug-03-17 08:09PM  AstraZeneca plc: Buy the Dip? Motley Fool
11:53AM  AstraZeneca's Other Pharmaceutical Products Need to Catch Up GuruFocus.com
09:12AM  The Zacks Analyst Blog Highlights: Merck, Citigroup, AstraZeneca, HSBC and Sprint Zacks
Aug-02-17 06:05PM  Top Research Reports for Merck, Citigroup & AstraZeneca Zacks
03:06PM  Forget BMY's Q2 Earnings, Watch Out For Opdivo Trials Going Forward Forbes
11:41AM  Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break? InvestorPlace
Aug-01-17 07:00AM  Acalabrutinib Granted Breakthrough Therapy Designation by US FDA for the Treatment of Patients with Mantle Cell Lymphoma Business Wire
04:34AM  AstraZeneca a tricky takeover target after big cancer drug blow Reuters
02:38AM  AstraZeneca gets breakthrough status for blood cancer drug Reuters
Jul-31-17 05:21PM  Foreign Stock Roundup: GSK, Shell, AstraZeneca Beat on Earnings Zacks
AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. Its marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; collaborations with FibroGen, Astellas, Pieris Pharmaceuticals Inc, Champions Oncology, Inc., and Takeda Pharmaceutical Company Limited; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E5.75 EPS (ttm)6.66 Insider Own5.80% Shs Outstand1.07B Perf Week-0.16%
Market Cap40.84B Forward P/E17.21 EPS next Y2.22 Insider Trans-0.40% Shs Float1.01B Perf Month9.88%
Income7.43B PEG0.76 EPS next Q0.48 Inst Own86.90% Short Float2.17% Perf Quarter8.91%
Sales9.16B P/S4.46 EPS this Y299.00% Inst Trans-1.07% Short Ratio2.58 Perf Half Y14.11%
Book/sh10.66 P/B3.59 EPS next Y11.15% ROA30.70% Target Price37.71 Perf Year19.64%
Cash/sh8.42 P/C4.54 EPS next 5Y7.52% ROE73.30% 52W Range27.28 - 38.87 Perf YTD28.83%
Dividend- P/FCF19.78 EPS past 5Y21.00% ROI30.60% 52W High-1.49% Beta1.35
Dividend %- Quick Ratio2.40 Sales past 5Y-5.10% Gross Margin76.90% 52W Low40.36% ATR0.59
Employees12600 Current Ratio2.40 Sales Q/Q4.40% Oper. Margin24.10% RSI (14)65.30 Volatility1.49% 1.61%
OptionableYes Debt/Eq1.00 EPS Q/Q-93.50% Profit Margin80.90% Rel Volume0.57 Prev Close38.25
ShortableYes LT Debt/Eq0.81 EarningsOct 19 AMC Payout0.00% Avg Volume8.48M Price38.29
Recom2.50 SMA203.29% SMA505.28% SMA20013.17% Volume4,851,899 Change0.10%
Sep-22-17Reiterated The Benchmark Company Buy $40 → $45
Sep-19-17Reiterated Aegis Capital Buy $42 → $44
Aug-16-17Initiated SunTrust Hold $38
Aug-08-17Resumed Mizuho Underperform $34
Jul-21-17Reiterated Canaccord Genuity Hold $32 → $34
Jul-19-17Reiterated The Benchmark Company Buy $39 → $40
Jul-13-17Reiterated Maxim Group Buy $36 → $40
Jun-27-17Reiterated Aegis Capital Buy $40 → $42
Jun-08-17Reiterated Citigroup Buy $36 → $41
Jun-05-17Upgrade Credit Suisse Neutral → Outperform
Apr-20-17Reiterated Canaccord Genuity Hold $31 → $32
Apr-20-17Downgrade Monness Crespi & Hardt Buy → Neutral
Apr-13-17Reiterated Aegis Capital Buy $38 → $40
Mar-29-17Initiated Barclays Overweight $41
Mar-29-17Initiated Barclays Overweight
Feb-17-17Resumed Pacific Crest Sector Weight
Jan-26-17Reiterated Stifel Hold $31 → $35
Jan-26-17Reiterated RBC Capital Mkts Sector Perform $32 → $34
Jan-26-17Reiterated Aegis Capital Buy $36 → $38
Jan-24-17Reiterated The Benchmark Company Buy $39 → $37
Sep-22-17 10:34AM  Smart Call: eBay Offers 20% More When Selling Your Old Phone PR Newswire
08:27AM  Sears Stock Is Suffering a Slow Death Thats Painful to Watch InvestorPlace
06:30AM  HPEs Meg Whitman Wont Be Ubers CEO. But She Could Be the First Female President Fortune
Sep-21-17 06:34PM  3 Stocks With eBay-like Return Potential Motley Fool
08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
Sep-20-17 08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
06:21AM  Dont Be Fooled: eBay (EBAY) Stock Is not a Turnaround Story at All InvestorPlace
Sep-19-17 01:39PM  Kohls once again teams up with Amazon Yahoo Finance Video
12:15PM  eBay Appoints Adriane Brown and Diana Farrell to its Board of Directors PR Newswire
Sep-18-17 03:44PM  StubHub and AXS Become Official Secondary Ticketing Market Partners of the NHL'S Vegas Golden Knights PR Newswire
11:23AM  3 Stocks That Could Put eBay's Returns to Shame Motley Fool
10:34AM  eBay and Spring Come Together for Fashion Deals on ebay.com Zacks
Sep-15-17 01:40PM  Amazon, eBay Accused of Tax Evasion by UK GuruFocus.com
01:25PM  T-Mobile Arena in Las Vegas Names StubHub, AXS as Official Secondary Ticketing Partners PR Newswire
10:40AM  Alibaba Has One of the Highest Average Revenues per User Market Realist
10:38AM  A Quick Survey of eBay Stock Market Realist
09:12AM  Why Groupons Debt-to-Equity Ratio Is One of Highest in Industry Market Realist
09:10AM  Is eBays Active Buyer Base Expanding? Market Realist
07:38AM  An Overview of eBays StubHub Business Market Realist
Sep-14-17 03:03PM  Want To Invest In E-Commerce? Check Out These 5 Ideas Benzinga
12:04PM  Amazon.com, Inc. (AMZN), eBay Inc (EBAY) Accused of Ignoring Tax Fraud InvestorPlace
10:37AM  Shedding Light on eBays New Buyback Program Market Realist
09:37AM  What eBays Executive Reset Indicates Market Realist
08:30AM  Ebay partners with Spring for online fashion boutique MarketWatch
08:09AM  eBay: A Global Leadership Reset Market Realist
Sep-13-17 07:39PM  Alibaba's Tsai Says China Is Wide Open to Competition Bloomberg Video
01:30PM  eBay and Spring Partner to Create Ultimate One-Stop Shopping Destination PR Newswire
08:04AM  HPE CEO Whitman Didn't Leave for Uber -- but She Still Might Depart This Fall Motley Fool
Sep-12-17 05:35PM  These Are the 10 Most Valuable Pieces of Military Memorabilia on eBay TheStreet.com
10:00AM  StubHub Announces Top 10 Fall US Tours: Bruno Mars Takes #1 Position PR Newswire
08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
Sep-11-17 10:05AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
08:17AM  eBay (EBAY) Touches a New 52-Week High on Expansion Deals Zacks
Sep-08-17 08:08AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
07:36AM  Why eBay Is Fighting to Protect a Trademark Market Realist
Sep-07-17 04:24PM  Stocks Close Mixed; eBay, These Other 5 Top Stocks Hit Buy Points Investor's Business Daily
12:08PM  Stocks Mixed, eBay Breaks Out; This Luxury Stock Jumped 40% Investor's Business Daily
11:04AM  Bids For Wu-Tang Clan Album Belonging To 'Pharma Bro' Shkreli Top $1 Million Forbes
10:37AM  Why eBay Is Expanding Its Cross-Border Business Market Realist
Sep-06-17 10:16PM  PayPal: Jefferies, Bernstein Positive Despite eBay Risk Barrons.com
04:48PM  PayPal Owns a Millennial-Friendly Business That Might Send Its Stock Soaring TheStreet.com
02:35PM  Why PayPal Still Has a Lot of Upside TheStreet.com
01:00PM  Martin Shkrelis One-of-a-Kind Wu-Tang Album Is Listed for Sale on EBay Bloomberg
10:09AM  Martin Shkreli has taken to eBay to sell the Wu-Tang Clan album he bought for $2 million Business Insider
09:57AM  Pharma Bro Martin Shkreli is selling his $2 million Wu Tang Clan album on eBay MarketWatch
Sep-05-17 11:19PM  eBay, Inc. Value Analysis (NASDAQ:EBAY) : September 6, 2017 Capital Cube
01:58PM  Why Alibaba Group Holding Ltd (BABA) Stock Is Heading Over $200 This Year InvestorPlace
11:30AM  eBay Turns Fashion Week into #MyFashionWeek with First-Ever Shoppable Fashion Illustrations PR Newswire
Sep-04-17 09:06AM  A Closer Look at Alibabas Valuation after Fiscal 1Q18 Market Realist
Sep-01-17 09:45AM  The Great British 'Shake Off': eBay Reveals Brits Most Likely to Shake Up Their Style Following Summer Holidays PR Newswire
09:23AM  Is eBay Stock a Buy? Motley Fool
07:20AM  Yahoo Finance Live: Market Movers - Sep 1st, 2017 Yahoo Finance Video
Aug-31-17 08:18AM  eBay, Inc. breached its 50 day moving average in a Bullish Manner : EBAY-US : August 31, 2017 Capital Cube
Aug-30-17 09:00PM  3 Reasons eBay Inc. Stock Could Rise Motley Fool
04:25PM  Sheryl Sandberg says HP CEO Meg Whitman taught her a hiring lesson she never forgot Business Insider
Aug-29-17 03:30PM  2 Reasons eBay Inc. Stock Could Fall Motley Fool
08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
Aug-28-17 09:40AM  Yahoo Finance Live: Midday Movers - Aug 28th, 2017 Yahoo Finance Video
09:06AM  A Closer Look at Twitters Valuation Market Realist
08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
Aug-25-17 06:44AM  eBay Caters for a Nation of Bargain Hunters with August Bank Holiday Deals PR Newswire
Aug-22-17 05:09PM  Macy's poaches its new president from Ebay Yahoo Finance Video
02:04PM  Macy's (M) Stock Gains on New Digital, Restructuring Initiatives Zacks
11:00AM  eBay Sends Students Back to College in Style with Olivia Culpo and Karl-Anthony Towns PR Newswire
10:50AM  Macy's eBay hire, Toll Brothers tumbles, Restaurant Brands jumps Yahoo Finance Video
10:11AM  Macy's Plucks eBay Exec, More Q2 Earnings: MDT, TOL, JASO Zacks
09:52AM  Macy's CEO says management changes, job cuts target faster sales, better margins CNBC
09:10AM  Macys Names eBay Exec as President to Improve E-Commerce Expertise 24/7 Wall St.
08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
07:54AM  One Sign Alibaba Isn't Held in the Same Regard as Amazon by Wall Street TheStreet.com
07:46AM  3 Stocks to Watch on Tuesday: Macys Inc (M), Tronc Inc (TRNC) and Coty Inc (COTY) InvestorPlace
07:12AM  EBay To Sell More African Goods in U.S. as MallforAfrica Tie-Up Expands Fortune
12:09AM  [$$] Macys Hires eBay Executive Amid Management Shakeup The Wall Street Journal
Aug-21-17 08:08PM  Can An eBay Executive, Big Data, And Exclusive Brands Save Macy's? Forbes
07:20PM  An eBay Shopping Spree Helped Bring This Power Plant Back Online Bloomberg
05:51PM  Macy's names senior eBay executive as president Associated Press
05:38PM  Macy's snags eBay exec, cuts 100 jobs amid management shake-up CNBC
04:52PM  Macy's names eBay executive Hal Lawton its new president CNBC Videos
04:50PM  [$$] Macy's Hires eBay Executive Amid Management Shakeup The Wall Street Journal
11:02AM  eBay Down 6.3% Since Earnings Report: Can It Rebound? Zacks
09:40AM  Is it safe to look at the Great American Eclipse through a selfie camera? MarketWatch
08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
07:00AM  eBay Announces Changes to its Regional Leadership Team PR Newswire
Aug-19-17 12:50PM  How You Can Tell Facebook Is Hungry to Change How People Use Its App TheStreet.com
Aug-18-17 09:50PM  Facebook Is Hungry to Change How Its Main App Is Used TheStreet.com
07:49PM  Better Buy: Shopify Inc. vs. eBay Inc. Motley Fool
05:17PM  Facebook (FB) Plans to Expand Its Marketplace Offerings Zacks
01:11PM  Investors Accept Seriously Flawed Analysts' Judgments About eBay's Fair Value Forbes
Aug-17-17 12:01PM  Innovation In Action: My Interview With EY's Global Chief Innovation Officer Jeff Wong Forbes
08:00AM  See what the IHS Markit Score report has to say about eBay Inc. Markit
06:03AM  Three of the Rarest Wonder Woman Comic Books of all Time to be Sold on eBay PR Newswire
06:03AM  Three of the Rarest Wonder Woman Comic Books of all Time to be Sold on eBay CNW Group
Aug-16-17 09:35PM  3 Stocks That Look Just Like eBay in 1998 Motley Fool
09:14PM  3 Must Read Stories: Alibaba Chases Amazon, Tencent Eyes AI, eBay vs Amazon Barrons.com
01:28PM  The American man who used eBay to get money from ISIS has pleaded guilty Business Insider
10:57AM  eBay, Facebook Team Up for Daily Deals on Mobile Marketplace Zacks
12:27AM  [$$] American Pleads Guilty to Accepting Islamic State Money to Fund Terrorism The Wall Street Journal
Aug-15-17 05:55PM  [$$] American Pleads Guilty to Accepting Islamic State Money to Fund Terrorism The Wall Street Journal
02:28PM  Facebook, eBay Team Up to Bring Daily Deals to Mobile Marketplace TheStreet.com
08:00AM  eBay Motors Brings Its '67 Ford Mustang Fastback to the Woodward Dream Cruise PR Newswire
eBay Inc. operates commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer their inventory for sale; and buyers to find and purchase it virtually. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com, and the StubHub mobile apps and Ticketbis platforms that connect fans with their favorite sporting events, shows, and artists, as well as enables them to buy and sell tickets. Its Classifieds platforms include a collection of brands, such as mobile.de, Kijiji, Gumtree, Marktplaats, eBay Kleinanzeigen, and others, which offer online classifieds to enable people find whatever they are looking for in their local communities. The company's platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels that include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Park Joo ManSVP, Asia PacificSep 15Option Exercise0.005,967035,005Sep 19 05:33 PM
Lee Jae HyunSVP, EMEASep 15Option Exercise0.006,1290105,541Sep 19 05:29 PM
Huber Marie OhSVP, GC & SecretarySep 15Option Exercise0.004,303059,511Sep 19 05:25 PM
FISHER STEPHENSVP, Chief Technology OfficerSep 15Option Exercise0.0012,550086,112Sep 19 05:22 PM
Doerger Brian J.VP, Chief Accounting OfficerSep 15Option Exercise0.007,843027,751Sep 19 05:18 PM
Cutler ScottSVP, AmericasSep 15Option Exercise0.0012,144026,341Sep 19 05:11 PM
Yetto Kristin ASVP, Chief People OfficerSep 15Option Exercise0.005,941064,004Sep 19 05:54 PM
WENIG DEVINPresident and CEOSep 15Option Exercise0.0023,5120489,982Sep 19 05:49 PM
Schenkel Scott F.SVP, Chief Financial OfficerSep 15Option Exercise0.0011,3570112,191Sep 19 05:42 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerSep 15Option Exercise0.009,860085,734Sep 19 05:37 PM
SWAN ROBERT HOLMESDirectorSep 07Sale37.5125,000937,805262,119Sep 11 06:22 PM
Lawton III Harry ASVP, North AmericaAug 14Option Exercise24.3737,570915,58183,058Aug 16 04:23 PM
Lawton III Harry ASVP, North AmericaAug 14Sale35.0034,8321,219,16248,226Aug 16 04:23 PM
Lawton III Harry ASVP, North AmericaJul 27Sale35.9313,000467,12845,488Jul 31 04:10 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 26Sale36.5610,450382,05324,001Jul 28 05:37 PM
FISHER STEPHENSVP, Chief Technology OfficerJul 24Option Exercise22.125,956131,75489,740Jul 26 05:00 PM
FISHER STEPHENSVP, Chief Technology OfficerJul 24Sale36.2411,956433,28180,100Jul 26 05:00 PM
WENIG DEVINPresident and CEOJul 17Option Exercise0.005,8930481,815Jul 18 07:28 PM
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,7680107,684Jul 18 07:23 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0018,355064,802Jun 19 09:32 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0018,355064,802Jun 19 09:16 PM
WENIG DEVINPresident and CEOJun 15Option Exercise0.0023,5130481,363Jun 19 09:13 PM
Todd Jeremy PaulSVP, EMEAJun 15Option Exercise0.0016,750096,481Jun 19 09:11 PM
Schenkel Scott F.Chief Financial OfficerJun 15Option Exercise0.0011,3580108,581Jun 19 09:08 PM
Lee Jae HyunSVP, Asia PacificJun 15Option Exercise0.006,130099,412Jun 19 09:04 PM
Lawton III Harry ASVP, North AmericaJun 15Option Exercise0.0046,099075,519Jun 19 09:00 PM
Huber Marie OhSVP, GC and SecretaryJun 15Option Exercise0.0033,359070,560Jun 19 08:57 PM
FISHER STEPHENSVP, CTOJun 15Option Exercise0.0012,551092,651Jun 19 08:54 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 15Option Exercise0.007,845037,076Jun 19 08:52 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerJun 15Option Exercise0.009,861084,011Jun 19 09:40 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 31Option Exercise22.1110,000221,139105,820Jun 02 07:54 PM
FISHER STEPHENSVP, Chief Technology OfficerMay 31Option Exercise21.206,452136,77984,733Jun 02 07:58 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 31Sale34.3235,0001,201,12476,306Jun 02 07:54 PM
FISHER STEPHENSVP, Chief Technology OfficerMay 31Sale34.696,452223,80880,100Jun 02 07:58 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaMay 31Sale34.376,204213,23693,282Jun 02 07:49 PM
SWAN ROBERT HOLMESDirectorMay 25Sale35.0025,000875,000286,562May 26 06:13 PM
Mitic Kathleen C.DirectorMay 18Sale33.8411,897402,56811,456May 22 07:32 PM
Lee Jae HyunSVP, Asia PacificMay 16Sale34.5720,000691,30198,605May 19 05:20 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 12Sale34.112,90399,03030,701May 15 07:25 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 04Sale33.5712,904433,20833,604May 08 06:15 PM
Hammer Bonnie SDirectorApr 27Option Exercise0.008,706012,417May 01 06:20 PM
ANDERSON FRED DDirectorApr 27Option Exercise0.008,706022,683May 01 06:14 PM
TIERNEY THOMAS JDirectorApr 27Option Exercise0.0012,664035,175May 01 05:46 PM
TRAQUINA PERRY MDirectorApr 27Option Exercise0.008,706018,666May 01 05:42 PM
PRESSLER PAUL SDirectorApr 27Option Exercise0.008,706022,916May 01 05:37 PM
BARNHOLT EDWARD WDirectorApr 27Option Exercise0.008,706021,183May 01 05:33 PM
Mitic Kathleen C.DirectorApr 27Option Exercise0.008,706023,353May 01 05:27 PM
SWAN ROBERT HOLMESDirectorApr 27Option Exercise0.008,7060310,961May 01 05:13 PM
Bates Anthony JohnDirectorApr 27Option Exercise0.008,706014,546May 01 05:07 PM
FISHER STEPHENSVP, CTOApr 24Option Exercise21.648,273179,044113,108Apr 26 05:37 PM
FISHER STEPHENSVP, CTOApr 24Sale32.3533,0081,067,91980,100Apr 26 05:37 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0012,4280118,605Apr 04 08:54 PM
Schenkel Scott F.Chief Financial OfficerApr 01Option Exercise0.0019,4930109,778Apr 04 08:36 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168092,294Apr 04 08:29 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,9730106,002Apr 03 08:23 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0012,903058,243Apr 03 08:26 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,323057,174Apr 03 08:30 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0061,3920495,684Apr 03 08:32 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,9190110,533Apr 03 08:36 PM
Huber Marie OhSVP, GC and SecretaryMar 15Option Exercise0.002,501042,811Mar 17 06:51 PM
Todd Jeremy PaulSVP, EMEAMar 15Option Exercise0.002,084076,232Mar 17 06:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMar 15Option Exercise0.004,559033,565Mar 17 06:46 PM
Schenkel Scott F.Chief Financial OfficerMar 15Option Exercise0.006,252093,548Mar 17 06:43 PM
Lawton III Harry ASVP, North AmericaMar 15Option Exercise0.003,647038,350Mar 17 06:41 PM
Lee Jae HyunSVP, Asia PacificMar 15Option Exercise0.003,1260106,177Mar 17 06:38 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMar 15Option Exercise0.005,731098,020Mar 17 06:35 PM
FISHER STEPHENSVP, CTOMar 15Option Exercise0.007,2940103,421Mar 17 06:32 PM
Yetto Kristin ASVP, Chief People OfficerMar 15Option Exercise0.003,126046,972Mar 17 06:29 PM
WENIG DEVINPresident and CEOMar 15Option Exercise0.0013,0860441,121Mar 17 06:26 PM
FISHER STEPHENSVP, CTOMar 01Option Exercise0.0045,8560135,543Mar 03 06:02 PM
Huber Marie OhSVP, GC and SecretaryMar 01Option Exercise0.0037,870040,310Mar 03 07:06 PM
Lee Jae HyunSVP, Asia PacificMar 01Option Exercise0.0026,2040103,051Mar 03 06:59 PM
Yetto Kristin ASVP, Chief People OfficerMar 01Option Exercise0.0049,538058,198Mar 03 06:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMar 01Option Exercise0.0032,7540111,597Mar 03 06:26 PM
Todd Jeremy PaulSVP, EMEAMar 01Option Exercise0.0013,103081,212Mar 03 07:24 PM
Lawton III Harry ASVP, North AmericaMar 01Option Exercise0.0037,870052,390Mar 03 07:12 PM
Lee Jae HyunSVP, Asia PaificFeb 27Sale33.986,375216,62976,847Mar 01 05:08 PM
Lawton III Harry ASVP, North AmericaFeb 23Sale33.7313,400451,92214,520Feb 27 07:49 PM
FISHER STEPHENSVP, CTOFeb 22Option Exercise21.6416,543358,02199,657Feb 23 06:33 PM
FISHER STEPHENSVP, CTOFeb 22Sale33.7716,601560,62189,687Feb 23 06:33 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Option Exercise23.0810,974253,27885,966Feb 21 07:40 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerFeb 17Sale33.6630,0101,010,00477,879Feb 21 07:40 PM
Lee Jae HyunSVP, Asia PacificFeb 16Sale34.118,000272,88483,222Feb 21 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerFeb 09Sale33.256,660221,43229,006Feb 10 05:21 PM
TIERNEY THOMAS JDirectorFeb 08Option Exercise9.856,01459,23828,525Feb 09 07:38 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Option Exercise22.6253,1271,201,614117,972Feb 10 05:15 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaFeb 08Sale32.7853,1271,741,57291,222Feb 10 05:15 PM
TIERNEY THOMAS JDirectorFeb 08Sale33.286,014200,15722,511Feb 09 07:38 PM
SWAN ROBERT HOLMESDirectorJan 30Option Exercise22.69125,6082,850,288442,401Jan 31 06:03 PM
SWAN ROBERT HOLMESDirectorJan 30Sale32.00200,6086,418,532301,633Jan 31 06:03 PM
Yetto Kristin ASVP, Chief People OfficerDec 15Option Exercise0.003,126023,966Dec 16 07:57 PM
FISHER STEPHENSVP, CTODec 15Option Exercise0.007,294093,552Dec 16 07:51 PM
WENIG DEVINPresident and CEODec 15Option Exercise0.0013,0860472,666Dec 16 07:47 PM
Schenkel Scott F.Chief Financial OfficerDec 15Option Exercise0.006,2520104,017Dec 19 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerDec 15Option Exercise0.00137,6430169,703Dec 19 07:38 PM
Lee Jae HyunSVP, Asia PacificDec 15Option Exercise0.003,126091,222Dec 19 07:32 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0018,487045,313Dec 19 07:28 PM
Lawton III Harry ASVP, North AmericaDec 15Option Exercise0.003,647029,824Dec 19 07:23 PM
Huber Marie OhSVP, GC and SecretaryDec 15Option Exercise0.002,501022,079Dec 19 07:17 PM
Todd Jeremy PaulSVP, EMEADec 15Option Exercise0.002,084069,233Dec 19 07:09 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E22.94 EPS (ttm)1.13 Insider Own32.21% Shs Outstand2.15B Perf Week-1.15%
Market Cap55.76B Forward P/E17.08 EPS next Y1.52 Insider Trans0.00% Shs Float1.46B Perf Month1.77%
Income2.69B PEG2.94 EPS next Q0.33 Inst Own38.00% Short Float1.87% Perf Quarter-0.46%
Sales26.33B P/S2.12 EPS this Y-20.90% Inst Trans2.70% Short Ratio7.51 Perf Half Y-4.36%
Book/sh10.57 P/B2.45 EPS next Y12.06% ROA5.20% Target Price32.44 Perf Year-5.24%
Cash/sh0.03 P/C924.79 EPS next 5Y7.80% ROE12.10% 52W Range24.01 - 30.25 Perf YTD-4.29%
Dividend1.68 P/FCF- EPS past 5Y-3.30% ROI7.80% 52W High-14.38% Beta0.91
Dividend %6.49% Quick Ratio0.40 Sales past 5Y-12.30% Gross Margin13.60% 52W Low7.87% ATR0.37
Employees6800 Current Ratio0.60 Sales Q/Q17.60% Oper. Margin14.40% RSI (14)42.49 Volatility0.99% 1.45%
OptionableYes Debt/Eq1.03 EPS Q/Q13.70% Profit Margin10.20% Rel Volume0.74 Prev Close25.88
ShortableYes LT Debt/Eq0.88 EarningsAug 03 BMO Payout128.30% Avg Volume3.64M Price25.90
Recom1.60 SMA20-0.39% SMA50-1.79% SMA200-4.41% Volume2,697,340 Change0.08%
Sep-01-17Reiterated Jefferies Buy $33 → $30
Jun-15-17Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-18-17Initiated Guggenheim Buy
Jan-31-17Reiterated Barclays Overweight $31 → $33
Nov-16-16Initiated Ladenburg Thalmann Buy
Sep-30-16Initiated Mizuho Buy $32
Sep-19-16Upgrade Credit Suisse Neutral → Outperform
Aug-31-16Reiterated Wunderlich Buy $33 → $32
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Sep-22-17 11:38AM  ONEOK Has Risen 6% since It Acquired ONEOK Partners Market Realist
10:47AM  This High-Yield Partnership Could Offer Retirees Sustainable Income Motley Fool
07:17AM  3 High-Yield Dividend Giants Still Worth Owning Motley Fool
Sep-21-17 10:31AM  The 2 Biggest Reasons Enterprise Products Partners L.P. Is a Better Dividend Stock Than Kinder Morgan Inc Motley Fool
10:21AM  This 10.9% Yield Is Safer Than It May Seem Motley Fool
Sep-20-17 01:46PM  How Does Holly Energy Partners' High-Yield Partnership Hold Up to Enterprise Products Partners? Motley Fool
Sep-19-17 04:30PM  Enterprise Products to Participate in J.P. Morgan Midwest Energy Infrastructure / MLP Conference Business Wire
06:02AM  3 Growth Stocks for Nest-Egg Building Motley Fool
Sep-18-17 01:00PM  What Drove MLPs Performance Last Week Market Realist
Sep-16-17 10:32AM  Losing Sleep Over Your Dividend Portfolio? Consider This High-Yield Partnership Motley Fool
12:00AM  Enterprise says fire nearly out at Texas NGL complex Reuters
Sep-15-17 07:00PM  3 High-Yield Dividend Stocks for September Motley Fool
08:07AM  Is Enterprise Products Partners LP (EPD) A Buy At Its Current Price? Simply Wall St.
Sep-14-17 07:32AM  This Is the Real Reason to Love High-Yielding Magellan Midstream Partners, L.P. Motley Fool
Sep-13-17 04:15PM  Enterprise Enters into New Revolving Credit Facilities to Extend Maturities Business Wire
01:16PM  The 3 Dividend Stocks You'll Wish You'd Bought 10 Years From Now Motley Fool
Sep-12-17 11:06AM  Better Buy: Enterprise Products Partners L.P. vs. Magellan Midstream Partners, L.P. Motley Fool
07:38AM  What Analysts Recommend for Kinder Morgan Market Realist
Sep-11-17 04:04PM  Kinder Morgan Underperformed Peers Last Week Market Realist
07:37AM  What Does WMBs Current Valuation Indicate? Market Realist
07:03AM  Better Dividend Buy: Enterprise Products Partners L.P. vs. Kinder Morgan, Inc. Motley Fool
Sep-08-17 10:37AM  Williams Companies Stock Trends and Technical Indicators Market Realist
Sep-07-17 04:11PM  6 MLPs With Sustainable Yields of 6% or More Barrons.com
06:35AM  Independent Oil & Gas Stock Performance Review -- Enbridge Energy Management, Enterprise Products Partners, EP Energy, and Resolute Energy PR Newswire
Sep-06-17 10:52AM  Why Kinder Morgan Inc. Shares Fell 5% in August, Lagging Its Midstream Peers Motley Fool
Sep-05-17 06:00PM  3 High-Yield Stocks Motley Fool
02:06PM  What Does Kinder Morgans Valuation Indicate? Market Realist
11:36AM  My 3 Biggest Stock Holdings Motley Fool
08:00AM  Enterprise Resumes Service at Substantially All of Its Major Assets Business Wire
07:00AM  Enterprise Products to Participate in Barclays CEO EnergyPower Conference Business Wire
Sep-04-17 05:00AM  Enterprise Products (EPD) Down 2.8% Since Earnings Report: Can It Rebound? Zacks
Sep-01-17 10:44AM  Enterprise Products Reports Minor Damages in Texas Plants Zacks
08:19AM  In Your 60s? 3 Stocks You Should Consider Buying Motley Fool
07:36AM  EPD, ETP, WPZ, and MMP: What Lies ahead for the MLP Giants Market Realist
Aug-31-17 06:17PM  ETFs with exposure to Enterprise Products Partners LP : August 31, 2017 Capital Cube
01:15PM  Enterprise Evaluating Potential Curtailment of Mont Belvieu NGL Fractionation & Storage Services Business Wire
10:36AM  How Energy Transfer Partners Valuation Stacks Up with Peers Market Realist
09:06AM  Short Interest in Enterprise Products and Magellan Rose Recently Market Realist
07:37AM  ETP and EPD: Are Institutional Investors Bullish? Market Realist
Aug-30-17 04:26PM  Center Coast MLP & Infrastructure Fund (CEN) Statement on Hurricane Harvey PR Newswire
04:02PM  Update: LyondellBasell shuts several Houston-area facilities, Motiva reduces refinery capacity American City Business Journals
02:14PM  Harvey's Winds and Rain Shut Down U.S. LPG Exports to Asia Bloomberg
11:51AM  Despite Harvey's Wrath, MLPs Prove Resilient --- So Far Barrons.com
11:14AM  Enterprise Products Plants Partly Operational Amid Harvey Zacks
11:09AM  BofA Merrill Lynch Adds Position in Enterprise Products Partners Market Realist
10:37AM  Why Williams Partners Plans to Spend More Capital in 2017 Market Realist
09:08AM  EPD, ETP, MMP, and WPZ: In-Depth Leverage Analysis Market Realist
08:26AM  Bullish on Kinder Morgan Inc? Then You'll Love These High-Yielding Stocks Motley Fool
07:37AM  Whats Been Driving Magellan Midstream Partners Market Realist
Aug-29-17 06:06PM  EPD, ETP, WPZ, and MMP: Analyzing Distributable Cash Flow Growth Market Realist
05:30PM  3 High-Yield Stocks on Sale Motley Fool
04:29PM  Why Williams Partners Outperformed Peers Year-to-Date Market Realist
02:30PM  Enterprise Products Partners LP : EPD-US: Dividend Analysis : July 31st, 2017 (record date) : By the numbers : August 29, 2017 Capital Cube
12:09PM  Hurricane Harvey Impacted Energy MLPs Market Realist
12:09PM  MLPs Recovered Slightly in the Week Ending August 25 Market Realist
07:37AM  Energy Transfer Partners Mainly Received Buy Ratings Market Realist
Aug-28-17 04:20PM  Enterprise Reports Initial Assessment of Impacts from Tropical Storm Harvey Business Wire
11:47AM  Forget Kinder Morgan, Inc.: These 2 Stocks Are Better High-Yield Buys Motley Fool
11:43AM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 28, 2017 Capital Cube
Aug-27-17 07:23AM  Forget Magellan Midstream Partners, L.P.: These 2 Stocks are Better Buys for Income Investors Motley Fool
Aug-26-17 10:23AM  2 Pipeline Stocks That Turned $3,000 Into More Than $39,000 Motley Fool
Aug-25-17 02:38PM  Enterprise shuts Shoup gas plant in Corpus Christi due to Harvey Reuters
Aug-23-17 01:29PM  Check These Masters Of The Energy Sector: 13 High-Yield MLPs Forbes
11:15AM  Enterprise Products Partners Not Showing Bottoming Signs, Yet TheStreet.com
Aug-22-17 03:35PM  Is It the Right Time Now to Buy MLPs? Market Realist
02:35PM  Recent Institutional Activity in Enterprise Products Partners Market Realist
02:32PM  Energy: Value play or value trap? CNBC Videos
01:05PM  Analyzing the Short Interest in Enterprise Products Partners Market Realist
12:10PM  MLPs Woes Continue on Crude Price Fall Market Realist
11:16AM  Enterprise Products Partners Has Outperformed Its Peers in 2017 Market Realist
08:12AM  Forget Helmerich & Payne, Inc.: These 3 Stocks Are Better Buys Motley Fool
Aug-21-17 07:04PM  Cramer's lightning round: The weather didn't go Chesapeak... CNBC Videos
06:51PM  Cramer's lightning round: The weather didn't go Chesapeake's way this year CNBC
08:43AM  The Zacks Analyst Blog Highlights: Cisco, Enterprise Products Partners, Prudential, Public Storage and United Continental Zacks
07:32AM  Better Buy: Kinder Morgan, Inc. vs. Enterprise Products Partners L.P. Motley Fool
Aug-19-17 10:46AM  3 Great Stocks You Can Buy on Sale Motley Fool
Aug-18-17 04:02PM  Top Stock Reports for Cisco, Enterprise Products Partners & Prudential Zacks
Aug-17-17 04:17PM  Why Enterprise Products Partners L.P. Shareholders Have Nothing to Worry About Motley Fool
Aug-16-17 08:50PM  Enterprise Products Partners LP Value Analysis (NYSE:EPD) : August 17, 2017 Capital Cube
03:03PM  [$$] Three Favorites in Midstream, MLPs Barrons.com
02:36PM  Analyzing ONEOKs 2017 Natural Gas Pipelines Capacity Market Realist
09:29AM  What Do Permian Changes Mean For Pipelines? Barrons.com
Aug-15-17 10:36AM  What Wall Street Analysts Price Targets for ONEOK Indicate Market Realist
09:06AM  Is ONEOK Stock Currently Overvalued? Market Realist
08:30AM  Enterprise Products to Participate in Citi Conference Business Wire
Aug-12-17 10:49AM  3 Top Stocks for Low-Risk Investors Motley Fool
09:50AM  Edited Transcript of EPD earnings conference call or presentation 3-Aug-17 2:00pm GMT Thomson Reuters StreetEvents
Aug-10-17 02:53PM  What Drove Energy Transfer Partners 2Q17 Earnings Growth Market Realist
01:34PM  How Large-Cap MLPs Fared in 2Q17 Market Realist
11:15AM  Why Enterprise Products Partners L.P. Is a Retiree's Dream Stock Motley Fool
Aug-09-17 06:07PM  Startup Permico joins crowded field looking to build Texas NGL pipelines Reuters
08:56AM  Enterprise Products to Participate in Goldman Sachs Conference Business Wire
Aug-08-17 12:28PM  Why MLPs Were Weak Last Week Market Realist
11:05AM  Does Kinder Morgans Valuation Look Attractive? Market Realist
07:10AM  Featured Company News - Murphy Oil Announces Pricing of $550 Million of Notes Due 2025 ACCESSWIRE
Aug-07-17 04:41PM  Enterprise Prices $1.7 Billion Principal Amount of Junior Subordinated Notes Business Wire
04:36PM  Enterprise Products (EPD) Misses on Q2 Earnings & Revenues Zacks
02:39PM  Natural Gas: 'Efficiency Improvements are Terrifying' Barrons.com
10:02AM  Enterprise Products Operating, LLC -- Moody's rates Enterprise Products' new junior subordinated notes Baa2 Moody's
09:35AM  Houston energy co. hires former Norton Rose Fulbright, Enterprise Products lawyer American City Business Journals
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,670 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas and ethane export terminals, and related operations. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 440 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,120 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 686 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates approximately 4,250 miles of refined products pipelines; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Edwin EAdvisory DirectorMar 06Sale28.0215,000420,300420,654Mar 06 05:18 PM
HACKETT JAMES TDirectorFeb 03Buy28.6533,000945,45033,000Feb 06 04:14 PM
BARTH CARIN MARCYDirectorNov 16Buy25.274,000101,08013,126Nov 16 04:50 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-3.27 Insider Own2.30% Shs Outstand350.22M Perf Week1.72%
Market Cap4.98B Forward P/E4.06 EPS next Y3.50 Insider Trans0.37% Shs Float343.64M Perf Month-0.84%
Income-1143.00M PEG- EPS next Q0.92 Inst Own66.80% Short Float11.66% Perf Quarter-8.19%
Sales9.22B P/S0.54 EPS this Y-714.90% Inst Trans20.04% Short Ratio2.47 Perf Half Y31.03%
Book/sh11.23 P/B1.27 EPS next Y-5.12% ROA-2.60% Target Price- Perf Year-47.24%
Cash/sh3.47 P/C4.11 EPS next 5Y-9.43% ROE-30.20% 52W Range8.31 - 27.84 Perf YTD-2.00%
Dividend- P/FCF2.28 EPS past 5Y61.43% ROI-1.60% 52W High-49.68% Beta-0.38
Dividend %- Quick Ratio1.10 Sales past 5Y31.90% Gross Margin72.20% 52W Low68.57% ATR0.47
Employees21500 Current Ratio1.30 Sales Q/Q-7.70% Oper. Margin-4.20% RSI (14)44.05 Volatility2.95% 3.40%
OptionableYes Debt/Eq7.28 EPS Q/Q87.60% Profit Margin-12.40% Rel Volume0.29 Prev Close14.23
ShortableYes LT Debt/Eq7.03 EarningsAug 08 BMO Payout- Avg Volume16.23M Price14.01
Recom3.00 SMA201.50% SMA50-6.71% SMA2002.34% Volume4,756,705 Change-1.55%
Aug-03-17Reiterated RBC Capital Mkts Sector Perform $19 → $21
Jun-16-17Initiated Cantor Fitzgerald Overweight $18
May-10-17Reiterated RBC Capital Mkts Sector Perform $18 → $19
Apr-20-17Reiterated JP Morgan Neutral $15 → $10
Mar-23-17Reiterated RBC Capital Mkts Sector Perform $21 → $18
Mar-06-17Reiterated Rodman & Renshaw Neutral $23 → $17
Feb-27-17Reiterated Mizuho Underperform $11 → $9
Feb-14-17Reiterated RBC Capital Mkts Sector Perform $29 → $22
Feb-10-17Reiterated Barclays Equal Weight $34 → $20
Jan-04-17Reiterated Piper Jaffray Underweight $16 → $11
Dec-15-16Downgrade Morgan Stanley Overweight → Equal-Weight $25 → $17
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
Nov-09-16Reiterated RBC Capital Mkts Sector Perform $35 → $29
Oct-14-16Reiterated Deutsche Bank Hold $30 → $29
Oct-12-16Reiterated RBC Capital Mkts Sector Perform $36 → $35
Sep-20-16Resumed Deutsche Bank Hold $30
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Sep-22-17 01:25PM  Generic Drug Makers Face Pricing Issues That Other Pharmas Don't Investor's Business Daily
Sep-21-17 09:55AM  Should Value Investors Consider Valeant Pharmaceuticals International (VRX) Stock? Zacks
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
Sep-19-17 11:01AM  GlassHouse: NuVasive Using The 'Valeant Playbook' To Deceive Investors Benzinga
Sep-18-17 10:33AM  Valeant Pharmaceuticals: Is A New Drug Approval On The Horizon? Barrons.com
09:54AM  What You Should Know About The Drug Approval Valeant Could Receive This Week Benzinga
07:00AM  Valeant To Participate At The Cantor Fitzgerald Global Healthcare Conference CNW Group
Sep-15-17 09:00AM  Valeant Commits $200,000 to Support Hurricane Relief Efforts CNW Group
08:26AM  Own Alphabet Inc. Stock? Antitrust Is on the Horizon InvestorPlace
Sep-12-17 09:14AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is STILL Too Ugly to Buy InvestorPlace
08:01AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
08:00AM  Today's Research Reports on Trending Tickers: Endo International and Valeant Pharmaceuticals ACCESSWIRE
Sep-11-17 02:35PM  DST faces class action over profit-sharing plan American City Business Journals
09:49AM  Buy Amazon, short Valeant among the top picks out of last year's Delivering Alpha CNBC
Sep-08-17 02:00PM  Follow the Crucial '$20 Level Rule' When Trading Stocks TheStreet.com
10:06AM  This Clear Catalyst Sent Valeant Pharmaceuticals Intl. Inc. 18% Lower in August Motley Fool
08:00AM  $20 Should Be Your Cutoff Point TheStreet.com
Sep-06-17 07:00AM  Valeant To Participate At The Morgan Stanley Global Healthcare Conference PR Newswire
Sep-05-17 04:51PM  Why Mallinckrodt Got Crushed Barrons.com
09:20AM  Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118 PR Newswire
09:20AM  Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118 CNW Group
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
07:20AM  Corporate News Blog - Intellipharmaceutics International Announces Appointment of CFO ACCESSWIRE
Sep-02-17 12:03PM  Better Buy: Valeant Pharmaceuticals International, Inc. vs. Rite Aid Corporation Motley Fool
Sep-01-17 05:39PM  Valeant (VRX) Continues to Lose Ground: Can It Bounce Back? Zacks
09:19AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Be Just Fine InvestorPlace
09:02AM  The Simple Reason I Won't Buy Intrexon Motley Fool
Aug-31-17 09:30AM  Wilmington company sues former partner following work for Salix, Valeant American City Business Journals
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
Aug-30-17 02:27PM  A Group Of Investors Is On A Mission To Help Traders Give Back Through Charity Benzinga
08:00AM  Today's Research Reports on Trending Tickers: Rexahn Pharmaceuticals and Valeant Pharmaceuticals ACCESSWIRE
Aug-29-17 04:41PM  Why Finish Line Inc (FINL), Valeant Pharmaceuticals Intl Inc (VRX) and Best Buy Co Inc (BBY) Are 3 of Todays Worst Stocks InvestorPlace -6.96%
01:14PM  Valeant: No Fundamental Reasons for Today's Selloff? Barrons.com
12:43PM  Why Did Valeant Pharmaceuticals (VRX) Stock Fall Today? Zacks
10:23AM  Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic InvestorPlace
09:34AM  Valeant Pharmaceuticals: Weakness, Weakness Everywhere? Barrons.com
Aug-28-17 01:23PM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Falls on New Legal Battle InvestorPlace
07:23AM  Immune Designs quest for a cancer vaccine could go the distance MarketWatch
Aug-25-17 05:53PM  ETFs with exposure to Valeant Pharmaceuticals International, Inc. : August 25, 2017 Capital Cube
04:39PM  Why Ulta Beauty Inc (ULTA), Valeant Pharmaceuticals Intl Inc (VRX) and GameStop Corp. (GME) Are 3 of Todays Worst Stocks InvestorPlace
12:35PM  Is the Valeant Pharmaceuticals Intl Inc (VRX) Debt Situation Overblown? InvestorPlace
10:00AM  Valeant's Legal Bills Are Piling Up Following Latest Securities Fraud Lawsuit TheStreet.com
09:45AM  Valeant: The Long or Short of It Barrons.com
05:00AM  Valeants Latest Legal Threat Could Be Especially Costly Bloomberg
Aug-24-17 09:13AM  Here's the Simple Issue I Still Have With Valeant Pharmaceuticals (and Why You Shouldn't Buy) Motley Fool
Aug-21-17 09:34AM  What's The FDA Saying About Valeant's Manufacturing Facility Issues? Benzinga
08:01AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
08:00AM  Today's Research Reports on Stocks to Watch: Valeant Pharmaceuticals Intl Inc. and VIVUS Inc. ACCESSWIRE
Aug-18-17 09:53AM  Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Gamble You Can Win InvestorPlace
08:00AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
07:39AM  Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain TheStreet.com
Aug-17-17 11:27AM  Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Higher Today InvestorPlace
09:38AM  Valeant: Hard to Ignore the Positive Developments? Barrons.com
07:50AM  Valeants Tampa manufacturing plant on track for a better bill of health American City Business Journals
Aug-16-17 07:24PM  Valeant Pharmaceuticals: Cramer's Top Takeaways TheStreet.com
07:18PM  Valeant's Papa: 'It's been a challenging 15 months, but w... CNBC Videos
06:41PM  Valeant Pharmaceuticals CEO Joe Papa: 'It's been a challe... CNBC Videos
06:26PM  Valeant Pharmaceuticals CEO: 'It's been a challenging 15 months, but we've made great progress' CNBC
04:49PM  Valeant Pharma works to resolve FDA concerns at Tampa plant MarketWatch
04:15PM  Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility PR Newswire
04:15PM  Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility CNW Group
11:25AM  Valeant Pharmaceuticals International, Inc. :VRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
10:16AM  The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak InvestorPlace
Aug-14-17 11:49AM  The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant Zacks
Aug-12-17 08:01AM  See what the IHS Markit Score report has to say about Valeant Pharmaceuticals International Inc. Markit
Aug-11-17 10:20AM  When the drugmaker raised these heart drugs prices, patients stopped getting them MarketWatch
09:59AM  Valeant: Three Steps to a Recovery? Barrons.com
07:05AM  Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure Zacks
Aug-10-17 07:22PM  Robert Bruce Invests in Valvoline, 2 Pharmaceutical Companies GuruFocus.com
09:03AM  5 Reasons Valeant's Situation Could Get Worse Motley Fool
Aug-09-17 06:36PM  Valeant and Teva Share Similar Ambitions With Similar Pitfalls TheStreet.com -10.04%
06:05PM  Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy PR Newswire
06:05PM  Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy CNW Group
04:38PM  Earnings Hangover Sacks Valeant Pharmaceuticals' Stock, Sending Shares Down 10% Motley Fool
04:30PM  Why Priceline Group, Office Depot, and Valeant Pharmaceuticals International Slumped Today Motley Fool
04:15PM  Here's Why Progenics Pharmaceuticals, Inc. Lost Ground Today Motley Fool
04:04PM  CANADA STOCKS-TSX ends lower as Valeant, financials drag Reuters
03:23PM  Valeant Isn't Out Of The Woods Yet Benzinga
03:08PM  Valeant (VRX) Beats Q2 Earnings, Sales in Line, Trims View Zacks
12:02PM  Valeant Isn't Out of Trouble Yet, Debt Remains Difficult to Curb TheStreet.com
09:45AM  Wednesdays Vital Data: Bank of America Corp (BAC), SeaWorld Entertainment Inc. (SEAS) and BP plc (ADR) (BP) InvestorPlace
09:41AM  Valeant: A Plausible Path Forward? Barrons.com
09:32AM  Your first trade for Wednesday, August 9 CNBC
09:16AM  Finally! 3 Figures From Valeant's Second-Quarter Report That Demonstrate Improvement Motley Fool
08:20AM  Valeant is on track to reduce about $5 billion of debt. But it has more than $27 billion to go MarketWatch
08:10AM  Today's Research Reports on Stocks to Watch: Esperion Therapeutics and Valeant Pharmaceuticals ACCESSWIRE
07:40AM  Working on a turnaround, Valeant gets a setback from its Bausch & Lomb plant in Tampa American City Business Journals
Aug-08-17 06:03PM  Valeant Rises on Earnings Beat, Progress on Debt Repayment GuruFocus.com
05:58PM  Valeant reports 2Q loss Associated Press
04:34PM  Valeant Bonds Rise on Early Debt Repayment Barrons.com
03:15PM  [$$] Valeant/Teva: lost summer Financial Times
03:06PM  Valeant Pharmaceuticals: Bears Will Be Bears Barrons.com
02:34PM  Here's Why Valeant Pharmaceuticals Intl. Inc. Surged as Much as 10% Motley Fool
01:17PM  Valeant Shares Gain on Strength of Xifaxan Bloomberg Video
12:21PM  [$$] Valeant gains breathing room during recovery Financial Times
11:47AM  Valeant Pharmaceuticals' Debt Reduction Overshadows Drop in Revenue Motley Fool
11:45AM  Valeant says it will exceed debt repayment target, shares surge Reuters
11:35AM  Valeant: Time, Time, Time is on My Side Barrons.com
11:28AM  Valeant's Guidance Gymnastics Point to a Cut Bloomberg
11:05AM  Is This the Turnaround Valeant Pharma Has Been Waiting For? 24/7 Wall St.
Valeant Pharmaceuticals International, Inc. operates as a pharmaceutical and medical device company worldwide. It operates in three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The company offers Lotemax gel for the treatment of inflammation and pain following ocular surgery; Ocuvite, a lutein eye vitamin and mineral supplement; PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus products; Biotrue multi-purpose solution for healthy contact lens wear; Artelac to treat dry eyes; Boston, a cleansing solution for gas permeable contact lenses; and Bedoyecta, a vitamin B complex. It also provides SofLens daily disposable contact lenses; ophthalmic surgical products; PureVision, a silicone hydrogel; Biotrue ONEday daily disposable contact lenses; Bausch + Lomb Ultra, a silicone hydrogel replacement contact lens; and medical device systems. In addition, the company offers Xifaxan for the treatment of irritable bowel syndrome; Provenge for the treatment of prostate cancer; Uceris to get ulcerative colitis under control; Arestin, a subgingival sustained-release antibiotic; Jublia for the treatment of onychomycosis; Solodyn for the treatment of acne; Elidel to treat skin conditions; and Glumetza tablets to enhance glycemic control. Further, it provides Wellbutrin XL for the treatment of major depressive disorder; Isuprel injections; Xenazine for the treatment of chorea; Nitropress for the reduction of blood pressure of patients in hypertensive crises; Cuprimine to treat Wilson's disease; Zegerid to treat certain stomach and esophagus problems; Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; and Latanoprost medicines to treat a type of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DE SCHUTTER RICHARD UDirectorAug 21Buy14.3310,000143,29682,379Aug 22 04:39 PM
DE SCHUTTER RICHARD UDirectorMay 11Buy13.9020,000278,00070,572May 15 05:19 PM
DE SCHUTTER RICHARD UDirectorMar 15Buy10.8010,000108,00025,190Mar 16 05:12 PM
Herendeen PaulEVP and CFOMar 14Buy10.7224,000257,280174,000Mar 16 05:04 PM
ValueAct Holdings, L.P.DirectorMar 14Buy10.823,000,00032,465,00016,937,431Mar 16 04:31 PM
Pershing Square Capital ManageDirectorMar 13Sale11.0018,114,432199,258,7520Mar 14 04:14 PM
Ross Thomas W. Sr.DirectorDec 14Buy14.735,00073,65026,822Dec 16 04:19 PM
Pershing Square Capital ManageDirectorDec 12Sale14.853,476,69051,628,84718,114,432Dec 13 04:14 PM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E10.64 EPS (ttm)9.01 Insider Own19.85% Shs Outstand392.73M Perf Week1.44%
Market Cap37.62B Forward P/E10.55 EPS next Y9.08 Insider Trans0.00% Shs Float317.23M Perf Month7.91%
Income3.66B PEG1.64 EPS next Q2.58 Inst Own77.50% Short Float4.14% Perf Quarter19.72%
Sales31.95B P/S1.18 EPS this Y-4.70% Inst Trans-0.43% Short Ratio5.59 Perf Half Y8.48%
Book/sh17.12 P/B5.60 EPS next Y-8.19% ROA15.40% Target Price95.91 Perf Year22.59%
Cash/sh5.12 P/C18.70 EPS next 5Y6.50% ROE57.20% 52W Range75.76 - 97.64 Perf YTD11.67%
Dividend3.60 P/FCF19.79 EPS past 5Y16.00% ROI24.40% 52W High-0.79% Beta1.02
Dividend %3.76% Quick Ratio1.50 Sales past 5Y-9.50% Gross Margin19.00% 52W Low27.86% ATR1.35
Employees13000 Current Ratio2.40 Sales Q/Q14.70% Oper. Margin15.90% RSI (14)73.77 Volatility1.28% 1.49%
OptionableYes Debt/Eq1.32 EPS Q/Q10.80% Profit Margin11.40% Rel Volume0.61 Prev Close95.79
ShortableYes LT Debt/Eq1.24 EarningsOct 27 BMO Payout38.50% Avg Volume2.35M Price96.87
Recom2.70 SMA204.65% SMA508.02% SMA20010.39% Volume1,429,502 Change1.13%
Jun-26-17Initiated HSBC Securities Buy $101
May-08-17Downgrade BofA/Merrill Buy → Underperform
Feb-10-17Downgrade Susquehanna Positive → Neutral
Feb-06-17Reiterated RBC Capital Mkts Sector Perform $92 → $95
Dec-29-16Reiterated Cowen Market Perform $87 → $90
Oct-14-16Initiated Tudor Pickering Buy
Sep-13-16Reiterated Deutsche Bank Hold $80 → $83
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Sep-21-17 01:05PM  LyondellBasell receives European Innovation Award from Plastics Europe for a smart polymer with "self-healing" properties PR Newswire
10:31AM  3 Top Dividend Stocks in the Chemicals Industry Motley Fool
08:02AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
01:01AM  LyondellBasell Begins Production at New PP Compounding Plant in Dalian, China PR Newswire
Sep-20-17 08:02AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
Sep-19-17 03:03PM  Is It Time To Buy LyondellBasell Industries NV (LYB) Based Off Its PE Ratio? Simply Wall St.
08:02AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
07:37AM  What Eastman Chemicals Valuations Suggest Market Realist
Sep-14-17 08:02AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
Sep-13-17 08:03AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
Sep-12-17 08:03AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
Sep-11-17 06:24PM  LyondellBasell Celebrates 18th Annual Global Care Day PR Newswire
09:07AM  LyondellBasell Stock Rebounded, Underperformed Its Peers Market Realist
08:03AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
07:37AM  Is LyondellBasell Stock Undervalued Compared to Its Peer? Market Realist
Sep-08-17 03:06PM  LyondellBasell: Analysts Views and Recommendations Market Realist
01:35PM  Is LyondellBasells Dividend Yield the Best among Its Peers? Market Realist
12:01PM  Analyzing LyondellBasells 3Q17 Dividend Market Realist
Sep-07-17 03:00AM  IBD Rating Upgrades: Lyondellbasell Ind A Nv Flashes Improved Price Strength Investor's Business Daily
Sep-06-17 12:19AM  [$$] Judge Dismisses LyondellBasell Creditors Clawback Lawsuit The Wall Street Journal
Sep-05-17 07:46PM  [$$] Judge Dismisses LyondellBasell Creditors Clawback Lawsuit The Wall Street Journal
Sep-03-17 01:42PM  LyondellBasell Provides Needed Equipment to Hurricane Harvey Emergency Responders and Recovery Teams PR Newswire
Sep-02-17 09:00AM  LyondellBasell's Houston Refinery Donates Food to Families in Crisis in Wake of Hurricane Harvey PR Newswire
Aug-31-17 07:50AM  Dividend Coverage: This Basic Materials Stock has a Dividend Yield of 3.99%; Will Trade Ex-Dividend on September 01, 2017 ACCESSWIRE
Aug-30-17 04:02PM  Update: LyondellBasell shuts several Houston-area facilities, Motiva reduces refinery capacity American City Business Journals
02:37PM  LyondellBasell Supports Tropical Storm Relief Efforts in Lake Charles with Food Donation PR Newswire
Aug-29-17 05:08PM  LyondellBasell's Technology Selected for China HDPE Unit Zacks
01:16PM  LyondellBasell Donates $200,000 to the American Red Cross Texas Gulf Coast Region for Hurricane Relief PR Newswire
Aug-23-17 06:45AM  LyondellBasell Board Authorizes Quarterly Dividend PR Newswire
Aug-13-17 12:41AM  Edited Transcript of LYB earnings conference call or presentation 28-Jul-17 3:00pm GMT Thomson Reuters StreetEvents
Aug-12-17 08:06AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
Aug-09-17 08:07AM  See what the IHS Markit Score report has to say about LyondellBasell Industries NV. Markit
Aug-03-17 06:26PM  6 Undervalued Stocks Based on the Peter Lynch Value GuruFocus.com
02:11PM  LyondellBasell to Address Jefferies Industrials Conference PR Newswire
Jul-31-17 03:35PM  Analysts Views on LyondellBasell after Its 2Q17 Earnings Market Realist
02:06PM  Why Did LyondellBasells Revenue Rise in 2Q17? Market Realist
01:55PM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017 Capital Cube
12:06PM  LyondellBasell Stock Rose, Earnings Beat Estimates Market Realist
Jul-28-17 10:07PM  LyondellBasell beats 2Q profit forecasts Associated Press
10:24AM  LyondellBasell (LYB) Tops Q2 Earnings Estimates, Sales Trail Zacks
07:44AM  LyondellBasell (LYB) Q2 Earnings Beat Estimates, Sales Miss Zacks
06:45AM  LyondellBasell Reports Second Quarter 2017 Earnings PR Newswire
Jul-26-17 10:02AM  Will LyondellBasell (LYB) Disappoint this Earnings Season? Zacks
Jul-24-17 07:20AM  Featured Company News - LyondellBasell to Build the World's Largest PO/TBA Plant in Houston, Texas Accesswire
Jul-21-17 09:30AM  LyondellBasell gives final green light to $2.4B chemical plant in Houston area American City Business Journals
06:30AM  LyondellBasell to Build the World's Largest PO/TBA Plant in Texas PR Newswire
Jul-20-17 10:49AM  Is Surprise in the Cards for Materials ETFs in Q2 Earnings? Zacks
Jul-18-17 10:37AM  Whos LyondellBasell Cooking up a License Deal with Now? Market Realist
Jul-14-17 08:14AM  LyondellBasell to Discuss Second-Quarter Results on Friday, July 28, 2017 PR Newswire
Jul-10-17 09:06AM  Why Eastman Chemical Is Trading at a Premium to Its Peers Market Realist
Jul-03-17 12:59PM  LyondellBasell to Provide Specialized Training to Cologne Firefighters PR Newswire
Jun-29-17 03:44PM  LyondellBasell Industries NV Value Analysis (NYSE:LYB) : June 29, 2017 Capital Cube
09:07AM  Why LyondellBasell Is Trading at a Discount to Peers Market Realist
07:40AM  What Wall Street Analysts Recommend for LyondellBasell Market Realist
Jun-28-17 12:35PM  Is LyondellBasell Managing Its Interest Expenses Efficiently? Market Realist
11:05AM  LyondellBasells Debt Is on the Rise Market Realist
09:15AM  Is a Turnaround in the Cards for LyondellBasell? Market Realist
08:26AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : June 28, 2017 Capital Cube
Jun-26-17 11:18AM  Will Pandora Shares Soar to $16 -- or Plummet to $3.50? TheStreet.com
Jun-14-17 01:40PM  ETFs with exposure to LyondellBasell Industries NV : June 14, 2017 Capital Cube
Jun-02-17 12:16PM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : June 05th, 2017 (record date) : By the numbers : June 2, 2017 Capital Cube
May-30-17 12:33PM  ETFs with exposure to LyondellBasell Industries NV : May 30, 2017 Capital Cube
08:24AM  LyondellBasell Announces New Share Repurchase Program Market Realist
May-29-17 09:07AM  What Analysts Recommend for LyondellBasell Market Realist
08:12AM  LyondellBasell Hikes Dividend, Gets Nod for Share Repurchase Zacks
07:38AM  How LyondellBasells Dividend Yield Has Changed Market Realist
03:55AM  LyondellBasell (LYB) Down 7.7% Since Earnings Report: Can It Rebound? Zacks
May-26-17 05:22PM  LyondellBasell Pleases Investors with Dividend Increase Market Realist
May-24-17 06:45AM  LyondellBasell Announces Increase to Quarterly Dividend and Shareholder Approval of New Share Repurchase Program PR Newswire
May-23-17 09:00AM  LyondellBasell to Address Bernstein 33rd Annual Strategic Decisions Conference PR Newswire
May-22-17 05:39PM  LyondellBasell to Build Hyperzone Polyethylene Plant Market Realist
12:42PM  LyondellBasell Receives Five Top Safety Awards PR Newswire
May-16-17 04:10PM  LyondellBasell starts construction on Gulf Coast plant using new technology American City Business Journals
03:12PM  LyondellBasell to Address Barclays Americas Select Franchise Conference 2017 PR Newswire
09:22AM  LyondellBasell Starts Construction of New Plant at La Porte Zacks
May-15-17 05:01PM  LyondellBasell Begins Construction of Hyperzone PE Plant at its La Porte Complex PR Newswire
04:03PM  ETFs with exposure to LyondellBasell Industries NV : May 15, 2017 Capital Cube
May-08-17 10:21AM  Material ETFs Rise on Solid Q1 Earnings Zacks
09:07AM  Top Analyst Upgrades and Downgrades: Asure Software, Fluor, Lam Research, Newfield Exploration, Tesla, Yext and Many More 24/7 Wall St.
May-04-17 04:08PM  ETFs with exposure to LyondellBasell Industries NV : May 4, 2017 Capital Cube
May-03-17 10:11AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017 Capital Cube
10:03AM  LyondellBasell Among Top Donors to United Way of Greater Houston Campaign for 2016 PR Newswire
May-02-17 01:00PM  [$$] Chemical industry split about the case for more US plants Financial Times
10:36AM  Dow Chemicals Latest Valuations Post 1Q17 Earnings Market Realist
08:20AM  Edited Transcript of LYB earnings conference call or presentation 28-Apr-17 3:00pm GMT Thomson Reuters StreetEvents
Apr-28-17 03:31PM  LyondellBasell (LYB) Misses Q1 Earnings Estimates, Sales Top Zacks
07:55AM  LyondellBasell (LYB) Q1 Earnings Miss Estimates, Sales Beat Zacks
06:56AM  LyondellBasell misses 1Q profit forecasts Associated Press
06:45AM  LyondellBasell Reports First-Quarter 2017 Earnings PR Newswire
Apr-26-17 04:50PM  LyondellBasell (LYB) Q1 Earnings: What's in the Cards? Zacks
Apr-21-17 08:28PM  [$$] Judge Dismisses Most of Lyondell Bankruptcy Lawsuit The Wall Street Journal
08:27PM  [$$] Blavatnik cleared of fraud claims over Lyondell Chemical buyout Financial Times
10:50AM  What's in Store for Material ETFs in Q1 Earnings? Zacks
09:06AM  What Are Dow Chemicals Valuations ahead of 1Q17 Earnings? Market Realist
Apr-20-17 09:07AM  Why DuPont Trades at a Premium to Its Peers Market Realist
Apr-17-17 09:49AM  LyondellBasells ACP Polyethylene Technology to Be Used by Hengli Market Realist
Apr-14-17 11:30AM  LyondellBasell to Discuss First-Quarter Results on Friday, April 28, 2017 PR Newswire
Apr-05-17 09:29AM  Opening Bell, April 5, 2107 CNBC Videos
09:29AM  Opening Bell, April 5, 2107
Apr-03-17 11:20AM  LyondellBasell Industries NV : LYB-US: Dividend Analysis : March 06th, 2017 (record date) : By the numbers : April 3, 2017 Capital Cube
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers worldwide. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; polyolefins, such as polyethylene and polypropylene (PP); and PP homopolymers, copolymers, and compounds. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, methanol products, glacial acetic acids, vinyl acetate monomers, and ethylene oxides and derivatives. In addition, it refines crude oil into gasoline, diesel, and jet fuel; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts, as well as purchases and sells ethylene. The company also exports its products. LyondellBasell Industries N.V. was founded in 2005 and is based in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bindra Jagjeet S.DirectorAug 01Sale89.203,224287,5817,547Aug 02 06:39 PM
Roudeix RichardSVP, O&P - EAIMay 01Option Exercise40.002329,2805,086May 03 03:29 PM
AI New Holdings 2 LLC10% OwnerMar 09Sale89.12139,61712,441,96972,772Mar 10 04:12 PM
AI New Holdings 2 LLC10% OwnerMar 02Sale93.5039,4253,686,23872,912Mar 03 04:48 PM
AI New Holdings 2 LLC10% OwnerMar 01Sale94.32206,78719,504,43972,951Mar 03 04:48 PM
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Option Exercise78.2714,7691,155,95931,283Feb 22 08:13 PM
Wolf Jacquelyn HSVP, Human ResourcesFeb 22Sale94.0114,7691,388,41616,514Feb 22 08:13 PM
AI New Holdings 2 LLC10% OwnerFeb 22Sale94.5514,1711,339,85873,157Feb 24 04:04 PM
AI New Holdings 2 LLC10% OwnerFeb 13Sale92.24862,20579,532,80773,171Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 10Sale92.45305,70028,261,84374,030Feb 14 05:51 PM
AI New Holdings 2 LLC10% OwnerFeb 09Sale92.29900,00083,056,95074,334Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 08Sale91.591,132,095103,689,48775,231Feb 09 06:11 PM
AI New Holdings 2 LLC10% OwnerFeb 07Sale93.021,000,00093,018,14776,359Feb 09 06:11 PM
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E32.73 EPS (ttm)5.74 Insider Own0.20% Shs Outstand401.11M Perf Week-1.97%
Market Cap75.37B Forward P/E17.64 EPS next Y10.65 Insider Trans-5.92% Shs Float398.13M Perf Month6.29%
Income2.27B PEG2.80 EPS next Q2.25 Inst Own87.00% Short Float0.75% Perf Quarter7.09%
Sales19.20B P/S3.93 EPS this Y3.50% Inst Trans-1.00% Short Ratio2.04 Perf Half Y21.51%
Book/sh57.41 P/B3.27 EPS next Y13.94% ROA4.90% Target Price200.92 Perf Year20.90%
Cash/sh1.66 P/C113.43 EPS next 5Y11.70% ROE10.40% 52W Range139.07 - 194.30 Perf YTD33.18%
Dividend0.60 P/FCF30.33 EPS past 5Y13.90% ROI6.40% 52W High-3.09% Beta1.06
Dividend %0.32% Quick Ratio1.00 Sales past 5Y9.60% Gross Margin45.90% 52W Low35.40% ATR2.34
Employees55000 Current Ratio1.50 Sales Q/Q10.00% Oper. Margin13.90% RSI (14)57.60 Volatility1.14% 1.26%
OptionableYes Debt/Eq0.75 EPS Q/Q19.50% Profit Margin11.80% Rel Volume0.58 Prev Close187.91
ShortableYes LT Debt/Eq0.68 EarningsOct 25 BMO Payout10.40% Avg Volume1.45M Price188.30
Recom1.50 SMA200.55% SMA504.11% SMA20014.44% Volume840,753 Change0.21%
Sep-06-17Resumed Morgan Stanley Overweight $220
Jul-20-17Upgrade Cleveland Research Neutral → Buy
May-19-17Initiated Cantor Fitzgerald Overweight $194
May-09-17Reiterated Barclays Overweight $175 → $190
Jan-18-17Initiated Deutsche Bank Buy $163
Nov-10-16Resumed Leerink Partners Outperform
Sep-22-16Resumed JP Morgan Overweight $180
Sep-09-16Downgrade Cleveland Research Buy → Neutral
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Sep-22-17 03:59PM  Valens Groworks Announces Strategic Collaboration Newsfile
11:19AM  ETFs with exposure to Thermo Fisher Scientific, Inc. : September 22, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about Thermo Fisher Scientific Inc. Markit
06:59AM  These life-science stocks provide biotech-like performance without the gyrations MarketWatch
Sep-20-17 11:28AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 20, 2017 Capital Cube
10:32AM  These high-flying life sciences stocks make Netflix and A... CNBC Videos
Sep-19-17 11:37AM  Catalent bolsters biopharma business with Cook Pharmica buy Reuters
Sep-18-17 10:33AM  Zacks.com featured highlights include Owens Corning, Thermo Fisher, Huntington Ingalls, Royal Caribbean Cruises and MKS Instruments Zacks
Sep-15-17 10:21AM  5 Unbeatable Dividend Stocks for Assured Growth Zacks
09:56AM  Thermo Fisher Fundamentals Impressive Amid Tough Competition Zacks
Sep-14-17 10:49AM  S&P 500 Nears 2,500: 5 Stock Picks for Big Profits Zacks
Sep-13-17 05:59PM  "Fast Money" final trades: TGT, TMO and more CNBC Videos
08:04AM  See what the IHS Markit Score report has to say about Thermo Fisher Scientific Inc. Markit
08:00AM  Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V. PR Newswire
Sep-12-17 09:38AM  Five Healthcare Stocks To Buy Before The End Of The Year Barrons.com
Sep-09-17 12:01AM  [$$] Morgan Stanley Applies Booster to Thermo Fisher Scientific Shares Barrons.com
Sep-08-17 10:24AM  The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, China Life Insurance, Deere and American Airlines Zacks
Sep-07-17 05:59PM  "Fast Money" final trades: SQ, MU and more CNBC Videos
04:44PM  Top Research Reports for Comcast, Thermo Fisher & China Life Insurance Zacks
10:01AM  8 Factors That Make Thermo Fisher a Valuable Pick Right Now Zacks
Sep-05-17 05:59PM  "Fast Money" final trades: HAL, BA, and more CNBC Videos
08:00AM  Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 11, 2017 PR Newswire
Aug-30-17 02:57PM  First FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific's CTS Dynabeads Technology PR Newswire
10:15AM  Thermo Fisher Acquires Patheon, Boosts Laboratory Products Zacks
10:07AM  Luminex Partners Sutter Health to Boost Molecular Testing Zacks
Aug-29-17 08:55AM  Thermo Fisher Scientific Completes Acquisition of Patheon PR Newswire
07:08AM  Thermo Fisher (TMO) Up 1.9% Since Earnings Report: Can It Continue? Zacks
Aug-24-17 09:24AM  Thermo Fisher's Patheon Buyout Gains Antitrust Clearance Zacks
Aug-23-17 04:05PM  Thermo Fisher Scientific Announces Receipt of All Required Regulatory Approvals for Proposed Acquisition of Patheon PR Newswire
09:01AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : August 23, 2017 Capital Cube
Aug-22-17 11:14AM  [$$] JMI Equity Backs Arena Solutions The Wall Street Journal
Aug-13-17 12:31AM  Edited Transcript of TMO earnings conference call or presentation 26-Jul-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-12-17 08:05AM  See what the IHS Markit Score report has to say about Thermo Fisher Scientific Inc. Markit
Aug-10-17 07:08PM  Thermo Fisher Scientific Prices Offering of Senior Notes PR Newswire
02:02PM  Thermo Fisher Scientific (Finance I) B.V. -- Moody's assigns Baa2 to Thermo Fisher's bond offering Moody's
Aug-09-17 11:15AM  Cramer: Secondary Offerings Get Primary Attention TheStreet.com
Aug-08-17 10:40PM  Thermo Fisher Scientific Prices Offering of Common Stock PR Newswire
06:20PM  Thermo Fisher Scientific, Inc. Value Analysis (NYSE:TMO) : August 8, 2017 Capital Cube
Aug-07-17 04:15PM  Thermo Fisher Scientific Announces $1.5 Billion Offering of Common Stock PR Newswire
04:14PM  Thermo Fisher Extends Cash Tender Offer for All Outstanding Shares of Patheon to Coordinate Offer Timing with Two Remaining Regulatory Approvals PR Newswire
08:37AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : August 7, 2017 Capital Cube
Aug-03-17 07:10AM  Earnings Review and Free Research Report: Thermo Fishers Revenue Jumped 10%; EPS Climbed 20% ACCESSWIRE
Aug-01-17 07:38AM  How Thermo Fisher Scientifics Stock Has Performed Market Realist
Jul-31-17 11:36AM  Why Thermo Fisher Scientific Raised Its 2017 Guidance Market Realist
10:05AM  Key Highlights from Thermo Fisher Scientifics 2Q17 Earnings Market Realist
08:14AM  What Analysts Recommend for Thermo Fisher Scientific Market Realist
08:00AM  Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017 PR Newswire
07:40AM  AmerisourceBergen (ABC) Q3 Earnings: Will It Disappoint? Zacks
Jul-27-17 01:55PM  Zimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales Zacks
12:02PM  Boston Scientific (BSX) Tops Q2 Earnings & Sales, View Up Zacks
09:15AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : July 27, 2017 Capital Cube
Jul-26-17 09:47PM  Thermo Fisher beats Street 2Q forecasts Associated Press
10:15AM  Thermo Fisher (TMO) Tops Q2 Earnings & Revenues, View Up Zacks
07:32AM  Thermo Fisher (TMO) Beats on Q2 Earnings & Sales Estimates Zacks
06:20AM  Investor Network: Thermo Fisher Scientific Inc. to Host Earnings Call Accesswire
06:00AM  Thermo Fisher quarterly results edge past estimates, ups forecast Reuters
06:00AM  Thermo Fisher Scientific Reports Second Quarter 2017 Results PR Newswire
Jul-25-17 09:59AM  Quest Diagnostics (DGX) Tops Q2 Earnings, Raises '17 View Zacks
09:32AM  Medical Instruments' Jul 26 Earnings Lineup: EW, TMO, VAR Zacks
08:33AM  Should You Buy Thermo Fisher Scientific Inc. (TMO) Ahead of Earnings? Zacks
Jul-24-17 01:05PM  Will Thermo Fisher Scientific See Earnings Growth in 2Q17? Market Realist
11:36AM  What Analysts Predict for Thermo Fishers 2Q17 Revenues Market Realist
09:50AM  What Do Analysts Recommend for Thermo Fisher Scientific? Market Realist
Jul-21-17 09:16AM  Boston Scientific (BSX) Q2 Earnings: What Awaits the Stock? Zacks
Jul-18-17 05:00PM  Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes PR Newswire
09:06AM  Will Thermo Fisher's (TMO) Q2 Earnings Surpass Expectations? Zacks
08:34AM  Thermo Fisher Scientific (Finance I) B.V. -- Moody's assigns Baa2 to Thermo Fisher's EUR bonds; outlook stable Moody's
Jul-17-17 04:15PM  Why Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock? Zacks
Jul-13-17 04:44PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : July 13, 2017 Capital Cube
09:07AM  TMOs Recent Developments in the Small Molecule Research Field Market Realist
07:38AM  TMOs Oncomine Target Test Launch Will Boost This Business Market Realist
Jul-12-17 05:35PM  Thermo Fisher Scientific Accelerates Its Semiconductor Sequencing Market Realist
04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend PR Newswire
03:57PM  Most Analysts Recommend Buys on Thermo Fisher Scientific Market Realist
11:13AM  5 Top Nanotechnology Stocks to Buy Motley Fool
Jul-10-17 10:13AM  Thermo Fisher at a 52-Week High: What's Driving the Stock? Zacks
Jul-03-17 08:00AM  Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2017 PR Newswire
Jun-30-17 03:28PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : June 30, 2017 Capital Cube
01:44PM  Why the US is losing the war on drug prices: trader Yahoo Finance
Jun-27-17 10:31AM  Thermo Fisher Gets FDA's PMA for Oncomine Dx Target Test Zacks
Jun-26-17 08:15AM  Featured Company News - Thermo Fisher's Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Gets Pre-market Approval from US FDA Accesswire
Jun-22-17 09:57AM  Why Hold Strategy is Apt for Thermo Fisher (TMO) Stock Now Zacks
Jun-20-17 03:19PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : June 20, 2017 Capital Cube
Jun-19-17 11:55AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Capital Cube
09:08AM  How Strykers Margins Are Driven by Its CTG Program Market Realist
Jun-15-17 11:09AM  Thermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : June 15th, 2017 (record date) : By the numbers : June 15, 2017 Capital Cube
Jun-13-17 11:56AM  PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria TheStreet.com
Jun-09-17 08:20AM  Earnings up at Patheon ahead of acquisition by Thermo Fisher American City Business Journals
Jun-05-17 09:06AM  Behind Thermo Fishers Recent Stock Performance Market Realist
08:00AM  Thermo Fisher Scientific Raises the Bar in Mass Spectrometry Innovation at ASMS 2017 PR Newswire
07:36AM  Thermo Fisher on the Street: Inside the Analyst Recommendations Market Realist
Jun-02-17 10:36AM  Understanding Thermo Fishers Capital Deployment Strategy Market Realist
09:06AM  What Does Thermo Fisher Want in the Clinical Mass Spectrometry Business? Market Realist
07:36AM  Inside Thermo Fishers Key Partnerships in Diagnostics Market Realist
Jun-01-17 10:37AM  Understanding Thermo Fishers Growth Strategy Market Realist
09:08AM  How Long Can Thermo Fisher Scientifics Asia-Pacific Growth Momentum Last? Market Realist
07:38AM  Thermo Fishers Next Big Deal in the Medical Device Industry Market Realist
May-31-17 05:35PM  Heres What Keeps Boosting Thermo Fishers Growth Market Realist
04:42PM  3 Top Gene-Sequencing Stocks Poised for Solid Growth Motley Fool
03:42PM  Key Highlights from Thermo Fishers 1Q17 Earnings Market Realist
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems to support clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers controlled temperature technology products; sample preparation and preservation equipment; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; and research and safety market channel, and biopharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HORNSTRA PETER EVP & Chief Accounting OfficerSep 05Option Exercise102.053,387345,65221,663Sep 06 06:14 PM
HORNSTRA PETER EVP & Chief Accounting OfficerSep 05Sale185.183,894721,09117,769Sep 06 06:14 PM
Shine Daniel PSenior Vice PresidentAug 30Sale180.972,026366,64520,682Aug 31 05:17 PM
HARRIS C MARTINDirectorAug 30Sale180.9736065,1495,312Aug 31 05:11 PM
HOOGASIAN SETH HSr. VP and Gen. CounselAug 28Sale177.804,140736,09225,518Aug 29 06:41 PM
MANZI JIM PDirectorAug 18Sale172.7210,3181,782,12528,439Aug 18 05:03 PM
MANZI JIM PDirectorAug 17Sale175.201,000175,20038,757Aug 18 05:03 PM
Williamson StephenSr. VP and CFOJun 05Sale176.262,500440,65037,790Jun 06 04:36 PM
CASPER MARC NChief Executive OfficerJun 01Sale172.7920,0003,455,800269,279Jun 02 04:36 PM
Shine Daniel PSenior Vice PresidentMay 24Option Exercise65.154,688305,42329,200May 25 05:29 PM
Shine Daniel PSenior Vice PresidentMay 24Sale171.884,688805,75024,512May 25 05:29 PM
Loewald Thomas WSenior Vice PresidentApr 27Sale168.761,532258,54041,277Apr 28 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 15Sale160.739,0791,459,26862,517Mar 16 05:11 PM
CASPER MARC NChief Executive OfficerMar 15Sale158.6020,0003,172,000289,279Mar 16 05:07 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 10Option Exercise126.229,9871,260,56081,583Mar 13 05:14 PM
WILVER PETER MExec. VP & Chief Admin OfficerMar 10Sale158.189,9871,579,74471,596Mar 13 05:14 PM
Loewald Thomas WSenior Vice PresidentMar 08Option Exercise73.247,675562,11750,484Mar 09 04:13 PM
Loewald Thomas WSenior Vice PresidentMar 08Sale157.397,6751,207,96842,809Mar 09 04:13 PM
Williamson StephenSr. VP and CFOMar 06Sale158.712,500396,77540,290Mar 08 05:15 PM
Loewald Thomas WSenior Vice PresidentMar 06Sale158.714,049642,61742,809Mar 08 05:12 PM
HOOGASIAN SETH HSr. VP and Gen. CounselMar 06Sale158.713,142498,66731,104Mar 08 05:10 PM
CRM Salesforce.com, inc. daily Stock Chart
CRM [NYSE]
Salesforce.com, inc.
IndexS&P 500 P/E- EPS (ttm)-0.12 Insider Own0.10% Shs Outstand723.79M Perf Week-0.46%
Market Cap68.66B Forward P/E55.73 EPS next Y1.70 Insider Trans-77.34% Shs Float681.82M Perf Month2.05%
Income-80.20M PEG- EPS next Q0.37 Inst Own88.30% Short Float2.55% Perf Quarter7.22%
Sales9.39B P/S7.31 EPS this Y457.90% Inst Trans1.97% Short Ratio4.34 Perf Half Y16.36%
Book/sh11.87 P/B7.99 EPS next Y29.33% ROA-0.50% Target Price107.24 Perf Year27.88%
Cash/sh4.84 P/C19.61 EPS next 5Y29.14% ROE-1.00% 52W Range66.43 - 98.22 Perf YTD38.56%
Dividend- P/FCF32.14 EPS past 5Y69.50% ROI2.10% 52W High-3.34% Beta1.25
Dividend %- Quick Ratio0.80 Sales past 5Y29.90% Gross Margin73.00% 52W Low42.92% ATR1.40
Employees25000 Current Ratio0.80 Sales Q/Q25.80% Oper. Margin0.20% RSI (14)52.18 Volatility1.31% 1.47%
OptionableYes Debt/Eq0.31 EPS Q/Q-92.60% Profit Margin-0.90% Rel Volume0.56 Prev Close94.86
ShortableYes LT Debt/Eq0.16 EarningsAug 22 AMC Payout- Avg Volume4.01M Price94.94
Recom1.90 SMA20-0.51% SMA502.73% SMA20012.09% Volume2,247,103 Change0.08%
Sep-06-17Initiated MoffettNathanson Buy
Aug-23-17Reiterated Stifel Buy $105 → $110
Aug-01-17Initiated Credit Suisse Outperform $110
Jun-27-17Initiated SunTrust Buy $110
May-19-17Reiterated Stifel Buy $100 → $105
May-15-17Reiterated The Benchmark Company Buy $100 → $110
May-15-17Reiterated BMO Capital Markets Outperform $92 → $100
Apr-27-17Initiated Credit Suisse Outperform $110
Mar-01-17Reiterated Wedbush Outperform $98 → $102
Feb-28-17Resumed Robert W. Baird Outperform $90
Feb-16-17Initiated Needham Hold
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $105 → $76
Jan-11-17Initiated Wells Fargo Outperform
Nov-18-16Reiterated Wedbush Outperform $96 → $98
Nov-18-16Reiterated Mizuho Buy $85 → $95
Nov-18-16Reiterated BMO Capital Markets Outperform $86 → $90
Oct-18-16Initiated Rosenblatt Buy $90
Sep-01-16Reiterated Wedbush Outperform $98 → $96
Sep-01-16Reiterated RBC Capital Mkts Outperform $91 → $85
Sep-01-16Reiterated Mizuho Buy $100 → $85
Sep-22-17 02:23PM  Zaius Working To Create The B2C CRM Category Forbes
08:01AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
06:56AM  Why Is Salesforce (CRM) Up 2% Since the Last Earnings Report? Zacks
Sep-21-17 05:46PM  Facebook arrives in San Francisco with city's largest office lease in three years American City Business Journals
08:30AM  Exclusive: Cisco Chairman John Chambers Is Joining the Board of This Tech Unicorn Fortune
08:01AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
08:00AM  Maersk Line Charts Course to Customer Success with Salesforce PR Newswire
07:08AM  Should You Buy Oracle (ORCL) Stock After 10% Correction? InvestorPlace
06:00AM  10 Stocks For The Next Tech Boom Investopedia
Sep-20-17 11:43AM  Adobe Stock Dinged By Marketing Software Bookings Miss Investor's Business Daily
09:39AM  Salesforce (CRM) Unveils $50M Fund for AI-Focused Start-Ups Zacks
08:02AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
Sep-19-17 05:59PM  "Fast Money" final trades: MLCO, CAR and more CNBC Videos
08:04AM  Salesforce to launch $50 million artificial intelligence fund Reuters
08:00AM  Salesforce Introduces Sales Cloud Einstein Forecasting, Celebrates One Year of Salesforce Einstein PR Newswire
Sep-18-17 08:00PM  How to Make Money on Booming Cloud Services Demand TheStreet.com
04:00PM  3 Stocks That Could Soar More Than Salesforce Motley Fool
01:34PM  No storm in this cloud name -- investors say this name co... CNBC Videos
Sep-15-17 04:30PM  Salesforce Chairman and CEO Marc Benioff to Speak at United Nations General Assembly and World Economic Forum Sustainable Development Impact Summit PR Newswire
01:02PM  Pounce on Oracle Corporation (ORCL) Stock Like a Champ InvestorPlace
07:34AM  Oracle Stock Falls on Disappointing Cloud Guidance TheStreet.com
Sep-14-17 07:26PM  3 ways to trade Tech CNBC Videos
04:31PM  Oracle Corporation (ORCL) Stock Is a Strong Buy After Q1 Earnings Beat InvestorPlace
04:18PM  Oracle Rising: FYQ1 Beats, Taunts Salesforce, Workday, Amazon Barrons.com
10:30AM  Oracle earnings: Cloud sales expected to top new software licenses for first time MarketWatch
Sep-12-17 10:43AM  Apple's iOS 11 May Be A Boon For Salesforce, Other Chat Partners Barrons.com
08:02AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
08:00AM  Salesforce.org Donates $12.2 Million to San Francisco and Oakland School Districts to Expand Computer Science Education PR Newswire
08:00AM  Salesforce aims to help immigrant students with donations to San Francisco, Oakland schools Business Insider
Sep-11-17 10:45AM  Microsoft Corporation (MSFT) Stock Is a Buy Thanks to 2 Businesses InvestorPlace
10:07AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
07:25AM  Earnings Review and Free Research Report: Salesforce.com's Adjusted Diluted EPS Soared 37.5% ACCESSWIRE
06:17AM  How Salesforce Is Leading The Way In Applying AI To Advanced Analytics Forbes
Sep-08-17 10:23AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
08:30AM  Salesforce Announces Appointment of Bernard J. Tyson to its Board of Directors PR Newswire
Sep-07-17 04:30PM  Salesforce Executive to Participate in Upcoming Investor Conference PR Newswire
07:05AM  Why Productized Analytics Must Have A Point Of View Forbes
Sep-06-17 04:11PM  Heres Why GE Shelved Plans to Build its Own Amazon-Like Cloud Fortune
10:50AM  Is There Now An Opportunity In Salesforcecom inc (CRM)? Simply Wall St.
10:07AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
07:35AM  This Stock Could Move A Lot Higher Zacks
Sep-04-17 08:02AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
Sep-02-17 08:08AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
Sep-01-17 07:23PM  ETFs with exposure to salesforce.com, inc. : September 1, 2017 Capital Cube
05:00PM  9 Ways to trade stocks at all-time highs CNBC Videos
10:13AM  Is Microsoft Corporation (MSFT) Stock Really All That Different Now? InvestorPlace
07:30AM  Cloud Software Is Booming -- Just Ask Workday and Salesforce TheStreet.com
Aug-31-17 09:24PM  Cloud Software Is Booming -- Just Ask Workday and Salesforce TheStreet.com
07:03PM  CEO of privately-held Informatica details 'agnostic' part... CNBC Videos
11:14AM  Microsoft Remains Top Dog in This Software Business Thanks to LinkedIn Fortune
11:06AM  How General Electric Company (GE) Stock Can Shock With a Rebound InvestorPlace
08:02AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
07:39AM  Why Salesforce Stock Fell despite Beating Estimates Market Realist
07:39AM  Salesforce Posts Strong Earnings and Revenues Market Realist
06:44AM  3 No-Brainer Stocks to Buy in Cloud Computing Motley Fool
Aug-30-17 10:08AM  How Lawyers Are Working to Change Their Industrys Diversity Problem Fortune
08:34AM  Why it is a Good Idea to Hold Salesforce (CRM) Stock for Now Zacks
Aug-29-17 01:24PM  salesforce.com, inc. :CRM-US: Earnings Analysis: Q2, 2018 By the Numbers : August 29, 2017 Capital Cube
09:57AM  Workday Inc (WDAY): Make Money or the Stock Gets It! InvestorPlace
08:03AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
07:50AM  Featured Company News - CDK Global Partners and ActivEngage Partner to Create "Concierge Chat" ACCESSWIRE
Aug-28-17 12:42PM  Earnings Calendar, Analyst Estimates And Stocks To Watch Investor's Business Daily
08:03AM  See what the IHS Markit Score report has to say about Salesforce.com Inc. Markit
Aug-27-17 10:18AM  Nothing to be worried about with Salesforce, analysts say MarketWatch
Aug-25-17 07:01PM  Cramers Exec Cut: CEOs reveal how government initiatives... CNBC Videos
01:24PM  Salesforce Grows Unimpeded by Increasing Competition GuruFocus.com
08:19AM  The Zacks Analyst Blog Highlights: TOTAL, Kimberly-Clark, Salesforce, AutoZone and Fujifilm Zacks
06:00AM  Weekly Wrap: Buffett's Still Got It Morningstar
Aug-24-17 07:30PM  Salesforce.com Surpasses $10 Billion Run Rate Motley Fool
06:42PM  In the absence of tax reform, 'we'll do the job for Congr... CNBC Videos
06:40PM  TurboTax parent's CEO: In the absence of tax reform, 'we'... CNBC Videos
06:06PM  3 Insightful Quotes From salesforce.com, Inc Management Motley Fool
05:26PM  Top Research Reports for TOTAL, Kimberly-Clark & Salesforce Zacks
04:59PM  salesforce.com, inc. Value Analysis (NYSE:CRM) : August 24, 2017 Capital Cube
12:19PM  Dollar Tree's results beat on strong sales at Family Dollar Reuters
11:45AM  3 Big Stock Charts for Thursday: Dollar Tree, Inc. (DLTR), Salesforce.com, Inc. (CRM) and HP Inc (HPQ) InvestorPlace
10:07AM  Company News For August 24, 2017 Zacks
Aug-23-17 08:10PM  Salesforce: Bulls Hike Targets, Look Past Muted 'Billings' Outlook Barrons.com
06:11PM  9 Must-See Metrics That Highlight salesforce.com, inc.'s Second Quarter Motley Fool
05:13PM  Salesforce Will Make You 20% Richer in No Time TheStreet.com
04:19PM  Stocks End Quietly Lower; HP Slumps Late On Earnings Investor's Business Daily
03:43PM  I Learned Something Important About Apple This Week TheStreet.com
03:15PM  What Wall Street Thinks About Salesforce's Q2 Earnings Benzinga
02:11PM  Edited Transcript of CRM earnings conference call or presentation 22-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
12:33PM  Salesforce (CRM) Hits All-Time High After Impressive Q2 Earnings Report Zacks
12:00PM  Salesforce Exceeds Expectations Again Morningstar
11:56AM  3 Marc Benioff Quotes Every Tech Investor Needs to See Zacks
11:37AM  Salesforce's Stellar Results Still Fall Short: What Wall Street's Saying TheStreet.com
11:07AM  Salesforce.com, Inc. (CRM) Stock Flirts With All-Time Highs After Tepid Earnings InvestorPlace
10:49AM  This Analyst Isn't Feeling Too Confident In Salesforce Benzinga
09:49AM  2 Big Surprises In The Salesforce Q2 Print Benzinga
09:45AM  Salesforce's Profit Guidance Disappointed, but Its Sales Momentum Remains Strong TheStreet.com
09:40AM  Stock Slump At Open; Nasdaq, S&P 500 Fall Below Support Investor's Business Daily
09:37AM  Wednesdays Vital Data: Lowes Companies, Inc. (LOW), Salesforce.com, Inc. (CRM) and Snap Inc (SNAP) InvestorPlace
09:17AM  Salesforce (CRM) Tops Q2 Earnings, Revenues, Lifts FY18 View Zacks
09:16AM  Another 'break out quarter' for Salesforce: Jim Cramer CNBC Videos
08:14AM  3 Stocks to Watch on Wednesday: Intuit Inc. (INTU), Salesforce.com, Inc. (CRM) and Wells Fargo & Co (WFC) InvestorPlace
07:51AM  Early movers: LOW, EXPR, CRM, GDDY, INTU, CREE, LZB & more CNBC
07:30AM  Salesforce Executive to Participate in Upcoming Investor Event PR Newswire
06:34AM  Salesforce.com: Cramer's Top Takeaways TheStreet.com
Salesforce.com, inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices, as well as solutions for partner relationship management. It also provides Service Cloud, which enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud to plan, personalize, and optimize one-to-one customer interactions. In addition, the company offers Commerce Cloud to deliver a digital commerce experience; Community Cloud to create and manage branded digital destinations for customers, partners, and employees; Internet of Things Cloud that provides insights to companies enabling them to sell, service, and market to their customers in personalized ways, as well as engage with them in real time; and Analytics Cloud that enables employees across an organization to explore business data, uncover new insights, make decisions, and take action from various devices. Further, it provides Salesforce Quip, a next-generation productivity solution for teams with a mobile-first strategy to collaborate without email; and Salesforce Platform for building enterprise apps. Additionally, the company offers professional cloud services, such as consulting, deployment, training, user-centric design, and integration to facilitate the adoption of its solutions; and architects and innovation program teams, as well as various education services comprising introductory online courses and advanced architecture certifications. Salesforce.com, inc. offers its services through direct sales; and through consulting firms, systems integrators, and other partners. The company was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BLOCK KEITHVice Chairman, Pres. and COOSep 19Option Exercise37.9510,000379,50014,718Sep 20 07:29 PM
Harris ParkerCo-Founder and CTOSep 19Option Exercise39.098,026313,75651,571Sep 20 07:24 PM
BLOCK KEITHVice Chairman, Pres. and COOSep 19Sale95.857,641732,4237,077Sep 20 07:29 PM
Harris ParkerCo-Founder and CTOSep 19Sale95.608,026767,26843,545Sep 20 07:24 PM
BLOCK KEITHPres., Vice Chairman and COOSep 14Option Exercise37.9510,000379,50012,359Sep 14 07:40 PM
BLOCK KEITHPres., Vice Chairman and COOSep 14Sale95.057,641726,2664,718Sep 14 07:40 PM
BLOCK KEITHPres., Vice Chairman and COOSep 12Option Exercise37.9510,000379,50010,000Sep 14 07:40 PM
Harris ParkerCo-FounderSep 12Option Exercise39.098,027313,79551,572Sep 14 07:59 PM
BLOCK KEITHPres., Vice Chairman and COOSep 12Sale96.937,641740,6252,359Sep 14 07:40 PM
Harris ParkerCo-FounderSep 12Sale96.578,027775,14143,545Sep 14 07:59 PM
Harris ParkerCo-FounderSep 05Option Exercise39.098,027313,79551,572Sep 05 07:38 PM
Harris ParkerCo-FounderSep 05Sale96.018,027770,69843,545Sep 05 07:38 PM
Hawkins Mark JChief Financial OfficerAug 31Option Exercise79.34111,6468,858,087126,926Aug 31 07:53 PM
Hawkins Mark JChief Financial OfficerAug 31Sale95.08111,64610,615,17515,280Aug 31 07:53 PM
Harris ParkerCo-FounderAug 29Option Exercise39.098,027313,79551,572Aug 29 08:40 PM
Martinez MariaPres., Sales & Cust. SuccessAug 29Sale92.7594087,18519,890Aug 29 08:37 PM
Harris ParkerCo-FounderAug 29Sale93.468,027750,24143,545Aug 29 08:40 PM
Allanson JoeChief Accounting OfficerAug 29Sale92.7561356,85628,753Aug 29 08:43 PM
Dayon AlexandrePres. & Chief Product OfficerAug 28Sale93.382,234208,61130,075Aug 28 08:57 PM
Harris ParkerCo-FounderAug 28Sale93.381,374128,30443,545Aug 28 09:00 PM
Allanson JoeChief Accounting OfficerAug 28Sale93.3837935,39129,366Aug 28 09:02 PM
Hawkins Mark JChief Financial OfficerAug 28Sale93.3899292,63315,280Aug 28 09:07 PM
Martinez MariaPres., Sales & Cust. SuccessAug 28Sale93.3872667,79420,830Aug 28 09:10 PM
Weaver Amy EPres., Legal & General CounselAug 28Sale93.381,03896,92818,116Aug 28 09:15 PM
Robbins Cynthia G.Pres. and Chief People OfficerAug 28Sale93.381,209112,8962,161Aug 28 09:18 PM
Harris ParkerCo-FounderAug 26Option Exercise0.001,085044,919Aug 28 09:00 PM
Dayon AlexandrePres. & Chief Product OfficerAug 26Option Exercise0.002,713032,309Aug 28 08:57 PM
Allanson JoeChief Accounting OfficerAug 26Option Exercise0.00452029,745Aug 28 09:02 PM
Hawkins Mark JChief Financial OfficerAug 26Option Exercise0.001,876016,272Aug 28 09:07 PM
Martinez MariaPres., Sales & Cust. SuccessAug 26Option Exercise0.00723021,556Aug 28 09:10 PM
Weaver Amy EPres., Legal & General CounselAug 26Option Exercise0.001,206019,154Aug 28 09:15 PM
Robbins Cynthia G.Pres. and Chief People OfficerAug 26Option Exercise0.001,20603,370Aug 28 09:18 PM
Dayon AlexandrePres. & Chief Product OfficerAug 25Option Exercise0.001,512029,596Aug 28 08:57 PM
Harris ParkerCo-FounderAug 25Option Exercise0.001,512043,834Aug 28 09:00 PM
Allanson JoeChief Accounting OfficerAug 25Option Exercise0.00540029,293Aug 28 09:02 PM
Martinez MariaPres., Sales & Cust. SuccessAug 25Option Exercise0.00648020,833Aug 28 09:10 PM
Weaver Amy EPres., Legal & General CounselAug 25Option Exercise0.00756017,948Aug 28 09:15 PM
Robbins Cynthia G.Pres. and Chief People OfficerAug 25Option Exercise0.001,08002,164Aug 28 09:18 PM
Allanson JoeChief Accounting OfficerAug 24Sale93.7019117,89728,753Aug 24 08:30 PM
Martinez MariaPres., Sales & Cust. SuccessAug 23Sale93.5224522,91220,185Aug 23 08:51 PM
Weaver Amy EPres., Legal & General CounselAug 23Sale93.52837,76217,192Aug 23 08:19 PM
Allanson JoeChief Accounting OfficerAug 23Sale93.5211811,03528,944Aug 23 08:34 PM
Hawkins Mark JChief Financial OfficerAug 23Sale93.5249045,82414,396Aug 23 08:37 PM
Harris ParkerCo-FounderAug 23Sale93.5249045,82442,322Aug 23 08:41 PM
Dayon AlexandrePres. & Chief Product OfficerAug 23Sale93.5265361,06828,084Aug 23 08:46 PM
Dayon AlexandrePres. & Chief Product OfficerAug 22Option Exercise0.001,235028,737Aug 23 08:46 PM
Harris ParkerCo-FounderAug 22Option Exercise0.00926042,812Aug 23 08:41 PM
Hawkins Mark JChief Financial OfficerAug 22Option Exercise0.00926014,886Aug 23 08:37 PM
Allanson JoeChief Accounting OfficerAug 22Option Exercise0.00309029,062Aug 23 08:34 PM
Weaver Amy EPres., Legal & General CounselAug 22Option Exercise0.00155017,275Aug 23 08:19 PM
Martinez MariaPres., Sales & Cust. SuccessAug 22Option Exercise0.00463020,430Aug 23 08:51 PM
Harris ParkerCo-FounderAug 22Option Exercise39.098,027313,79549,913Aug 22 09:16 PM
Harris ParkerCo-FounderAug 22Sale92.758,027744,46641,886Aug 22 09:16 PM
Roos John VictorDirectorAug 17Sale92.0021820,05615,230Aug 17 09:19 PM
Harris ParkerCo-FounderAug 15Option Exercise39.098,027313,79549,913Aug 15 07:43 PM
Conway CraigDirectorAug 15Sale90.6025022,6509,102Aug 15 06:51 PM
Harris ParkerCo-FounderAug 15Sale90.768,027728,50841,886Aug 15 07:43 PM
Roos John VictorDirectorAug 10Sale89.8322820,48115,448Aug 10 06:27 PM
Harris ParkerCo-FounderAug 08Option Exercise39.098,027313,79549,913Aug 09 06:22 PM
Harris ParkerCo-FounderAug 08Sale90.298,027724,79641,886Aug 09 06:22 PM
Benioff MarcChairman of the Board and CEOAug 07Option Exercise39.0910,000390,92534,195,300Aug 07 08:28 PM
Benioff MarcChairman of the Board and CEOAug 07Sale90.3910,000903,93834,185,300Aug 07 08:28 PM
Benioff MarcChairman of the Board and CEOAug 04Option Exercise39.0910,000390,92534,195,300Aug 07 08:28 PM
Benioff MarcChairman of the Board and CEOAug 04Sale90.4910,000904,92734,185,300Aug 07 08:28 PM
Benioff MarcChairman of the Board and CEOAug 03Option Exercise39.0910,000390,92534,195,300Aug 07 08:28 PM
Benioff MarcChairman of the Board and CEOAug 03Sale90.0310,000900,33834,185,300Aug 07 08:28 PM
Roos John VictorDirectorAug 03Sale90.0022820,52015,676Aug 07 08:36 PM
Benioff MarcChairman of the Board and CEOAug 02Option Exercise39.0910,000390,92534,195,300Aug 02 08:33 PM
Benioff MarcChairman of the Board and CEOAug 02Sale89.8310,000898,33534,185,300Aug 02 08:33 PM
Harris ParkerCo-FounderAug 01Option Exercise39.098,027313,79549,913Aug 01 08:40 PM
Benioff MarcChairman of the Board and CEOAug 01Option Exercise39.0910,000390,92534,195,300Aug 01 07:11 PM
Weaver Amy EPres., Legal & General CounselAug 01Option Exercise52.305,023262,70322,143Aug 01 08:43 PM
Harris ParkerCo-FounderAug 01Sale91.308,027732,83941,886Aug 01 08:40 PM
Benioff MarcChairman of the Board and CEOAug 01Sale91.3010,000913,03634,185,300Aug 01 07:11 PM
Weaver Amy EPres., Legal & General CounselAug 01Sale91.375,023458,95217,120Aug 01 08:43 PM
Benioff MarcChairman of the Board and CEOJul 31Option Exercise39.0910,000390,92534,195,300Aug 01 07:11 PM
Benioff MarcChairman of the Board and CEOJul 31Sale90.6810,000906,81134,185,300Aug 01 07:11 PM
Benioff MarcChairman of the Board and CEOJul 28Option Exercise39.0910,000390,92534,195,300Aug 01 07:11 PM
Martinez MariaPres., Sales & Cust. SuccessJul 28Sale90.1494084,73219,967Aug 01 08:00 PM
Benioff MarcChairman of the Board and CEOJul 28Sale90.6910,000906,94234,185,300Aug 01 07:11 PM
Martinez MariaPres., Sales & Cust. SuccessJul 27Option Exercise52.3010,000523,00030,907Jul 27 08:21 PM
Benioff MarcChairman of the Board and CEOJul 27Option Exercise39.0910,000390,92534,195,300Jul 27 08:33 PM
Martinez MariaPres., Sales & Cust. SuccessJul 27Sale92.0010,000920,00720,907Jul 27 08:21 PM
Roos John VictorDirectorJul 27Sale91.3122820,81915,904Jul 27 08:27 PM
Benioff MarcChairman of the Board and CEOJul 27Sale90.8910,000908,91134,185,300Jul 27 08:33 PM
Hawkins Mark JChief Financial OfficerJul 26Option Exercise59.648,625514,39522,585Jul 26 08:18 PM
Benioff MarcChairman of the Board and CEOJul 26Option Exercise39.0910,000390,92534,195,300Jul 26 08:24 PM
Hawkins Mark JChief Financial OfficerJul 26Sale90.508,625780,54413,960Jul 26 08:18 PM
Benioff MarcChairman of the Board and CEOJul 26Sale90.5910,000905,93034,185,300Jul 26 08:24 PM
Benioff MarcChairman of the Board and CEOJul 25Option Exercise39.0910,000390,92534,195,300Jul 25 08:26 PM
Harris ParkerCo-FounderJul 25Option Exercise39.098,027313,79549,913Jul 25 08:41 PM
Benioff MarcChairman of the Board and CEOJul 25Sale90.3810,000903,81834,185,300Jul 25 08:26 PM
Harris ParkerCo-FounderJul 25Sale90.388,027725,49741,886Jul 25 08:41 PM
Benioff MarcChairman of the Board and CEOJul 24Option Exercise39.0910,000390,92534,195,300Jul 24 08:38 PM
Benioff MarcChairman of the Board and CEOJul 24Sale89.4810,000894,83034,185,300Jul 24 08:38 PM
Robbins Cynthia G.EVP, Global Employee SuccessJul 24Sale89.3368160,8351,084Jul 24 08:41 PM
Weaver Amy EPres., Legal & General CounselJul 24Sale89.3368160,83517,120Jul 24 08:44 PM
Robbins Cynthia G.EVP, Global Employee SuccessJul 22Option Exercise0.001,28801,765Jul 24 08:41 PM
Weaver Amy EPres., Legal & General CounselJul 22Option Exercise0.001,288017,801Jul 24 08:44 PM
Benioff MarcChairman of the Board and CEOJul 21Option Exercise39.0910,000390,92534,195,300Jul 24 08:38 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-11.66 Insider Own0.20% Shs Outstand339.48M Perf Week-9.41%
Market Cap68.80B Forward P/E11.34 EPS next Y17.87 Insider Trans-0.26% Shs Float333.56M Perf Month-9.43%
Income-3981.80M PEG- EPS next Q4.15 Inst Own86.50% Short Float1.87% Perf Quarter-17.99%
Sales15.07B P/S4.57 EPS this Y63.30% Inst Trans-1.99% Short Ratio2.90 Perf Half Y-13.87%
Book/sh209.70 P/B0.97 EPS next Y9.99% ROA8.90% Target Price274.44 Perf Year-15.00%
Cash/sh17.16 P/C11.81 EPS next 5Y12.95% ROE15.70% 52W Range184.50 - 256.80 Perf YTD-3.50%
Dividend2.80 P/FCF270.12 EPS past 5Y-28.70% ROI0.10% 52W High-20.31% Beta1.18
Dividend %1.38% Quick Ratio1.10 Sales past 5Y26.00% Gross Margin87.10% 52W Low10.92% ATR5.22
Employees16700 Current Ratio1.20 Sales Q/Q8.80% Oper. Margin-20.80% RSI (14)24.64 Volatility3.02% 2.25%
OptionableYes Debt/Eq0.43 EPS Q/Q-88.00% Profit Margin77.30% Rel Volume1.81 Prev Close202.66
ShortableYes LT Debt/Eq0.38 EarningsAug 03 BMO Payout5.00% Avg Volume2.15M Price204.65
Recom2.10 SMA20-8.36% SMA50-12.61% SMA200-11.34% Volume3,895,301 Change0.98%
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Sep-22-17 03:04PM  Native American tribe moves to dismiss Allergan patent case Reuters
02:30PM  Native American tribe moves to dismiss Allergan patent case Reuters
12:42PM  Why Allergan's Hepatitis Drug Likely Won't Get FDA Approval Investor's Business Daily
12:01PM  Allergan Needs to Learn to Let Go Bloomberg
08:00AM  New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial PR Newswire
Sep-21-17 11:09AM  How Does Allergan plc (AGN) Affect Your Portfolio Returns? Simply Wall St.
10:15AM  How is the Age-Related Macular Degeneration Space Faring Now? Zacks
Sep-20-17 12:33PM  Allergan: Just How Far Will Big Pharma Go To Protect Its Patents? Barrons.com
08:04AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
04:00AM  Apple Likes the Patent Death Squad. Allergan Pays to Avoid It Bloomberg
12:24AM  [$$] States Push Ahead With Investigation Into Opioid Painkillers The Wall Street Journal
Sep-19-17 06:05PM  [$$] States Push Ahead With Investigation Into Opioid Painkillers The Wall Street Journal
02:55PM  States expand investigation of opioid makers, distributors Associated Press
12:22PM  State attorneys general subpoena opioid makers and dealer... CNBC Videos
11:58AM  The only thing Trump is doing to end the opioid crisis rewards the companies that started it Business Insider
09:35AM  Should Value Investors Consider Allergan plc (AGN) Stock Now? Zacks
07:35AM  Allergan Innovation Recognized With Three 2017 Allure Best of Beauty Breakthrough Awards PR Newswire
Sep-18-17 01:58PM  AMD leading IQ100 top gainers CNBC Videos
12:37PM  Why Allergan Could Be A $300 Stock Barrons.com
Sep-16-17 07:27AM  Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle TheStreet.com
Sep-15-17 01:56PM  U.S. senator slams Allergan patent deal with Native-American tribe Reuters
11:42AM  U.S. senator slams Allergan tribal patent deal Reuters
10:33AM  Amgen/Allergan's Avastin Biosimilar Secures FDA Approval Zacks
06:00AM  3 Dividend Healthcare Stocks Motley Fool
Sep-14-17 09:30PM  A Biosimilar Cure for Sky-High Cancer Drug Prices Motley Fool
05:23PM  Challenge of Allergan tribal patent deal in uncharted legal territory Reuters
03:28PM  Apple, JPMorgan Among Top Picks On New List From UBS Benzinga
03:12PM  Amgen and Allergan say FDA has approved biosimilar of Roche's Avastin MarketWatch
02:56PM  Allergan plc Ordinary Shares (AGN) May Have Just Saved Itself Billions InvestorPlace
02:54PM  FDA Approves Amgen And Allergan's MVASI (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer PR Newswire
11:22AM  These party drugs could become the answer for clinically ... CNBC Videos
11:12AM  AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs Zacks
08:02AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
Sep-13-17 05:59PM  "Fast Money" final trades: TGT, TMO and more CNBC Videos
04:41PM  Why pharma companies are scared of Bernies Medicare for All plan Quartz
08:03AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
07:43AM  Early movers: DIS, JWN, AAL, AGN, CNC, TEX, MU, MNK & more CNBC
Sep-12-17 06:16PM  Tech entity has tribal patent deal similar to Allergan's Reuters
05:15PM  Mylan says Allergan misusing tribal sovereignty in patent dispute Reuters
04:05PM  Allergan Launches New Brilliant Distinctions® Patient Loyalty Program PR Newswire
08:02AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
Sep-11-17 10:12PM  U.S. tribal patent deal could have big impact on generic drug market Reuters
07:56PM  Irma to Bring Droves to Aisles of Home Depot; Teva Reveals Savior CEO - ICYMI TheStreet.com
07:27PM  Cramer's lightning round: Allergan's in a torturous situa... CNBC Videos
07:22PM  U.S. tribal patent deal could have big impact on generic drug market Reuters
06:51PM  Cramer's lightning round: Allergan's in a torturous situation CNBC
06:22PM  U.S. tribal patent deal could have big impact on generic drug market Reuters
11:59AM  Why Did Teva Pharmaceuticals Stock Soar Today? Zacks
11:00AM  Here's Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August Motley Fool
10:07AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
09:26AM  Sovereign Immunity and Public Hangings Bloomberg
09:21AM  The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts PR Newswire
07:25AM  Allergan Patent Deal Isn't Just Unusual. It's Ugly. Bloomberg
07:17AM  Allergan's Patent Loophole Could Be a Huge Gift for Pfizer Motley Fool
Sep-10-17 08:33AM  3 Reasons to Buy Allergan plc Stock Right Now Motley Fool
01:00AM  The Media Is the Message; Allergan Gets Jiggy: Doug Kass' Views TheStreet.com
Sep-09-17 03:00AM  Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress PR Newswire
12:01AM  Casinos Aren't Enough as Native Tribe Makes Deal on Drug Patents Bloomberg
12:01AM  Casinos Arent Enough as Native Tribe Makes Deal on Drug Patents Bloomberg
Sep-08-17 11:43PM  [$$] Allergan Partners With Indian Tribe to Protect Drug Patents The Wall Street Journal
05:14PM  Allergan Shares Rise on Novel Patent Pact for Restasis TheStreet.com
04:29PM  [$$] Allergan Partners With Indian Tribe to Protect Drug Patents The Wall Street Journal
03:32PM  Allergan pays Mohawk Tribe to protect patents from challenges Reuters
03:29PM  Forget casinos: This Native American tribe is doing business in pharma patents CNBC
03:09PM  Allergan has made an unorthodox agreement with an American Indian tribe to fend off competition for its key product MarketWatch
02:45PM  Allergan pays Mohawk Tribe to protect patents from challenges Reuters
02:13PM  Forget casinos: This Native American tribe is doing business in pharma patents CNBC
02:08PM  Allergan $13.75 mln agreement with Saint Regis Mohawk Tribe a play to protect key dry eye product MarketWatch
01:43PM  Allergan reaches agreement regarding RESTASIS patents CNBC Videos
12:53PM  A Native American Tribe, a Drugmaker and an Unusual Patent Plan Bloomberg
12:34PM  Allergan and Saint Regis Mohawk Tribe Announce Agreements Regarding RESTASIS® Patents PR Newswire
11:07AM  [$$] Merck Tops JNJ, Allergan Barrons.com
08:01AM  Pro Football Hall of Famer Deion Sanders Tackles Frown Lines And Crow's Feet With BOTOX® Cosmetic (onabotulinumtoxinA)1 PR Newswire
Sep-07-17 09:41AM  Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan Zacks
08:45AM  Allergan Plc :AGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017 Capital Cube
07:20AM  Watertowns Lyndra strikes Alzheimers pact with Allergan worth up to $105M American City Business Journals
Sep-06-17 10:56AM  Is It The Right Time To Buy Allergan plc (AGN)? Simply Wall St.
07:35AM  Allergan to Present New Data on Chronic Migraine at the International Headache Congress in Vancouver PR Newswire
Sep-05-17 04:51PM  Why Mallinckrodt Got Crushed Barrons.com
Sep-04-17 08:45AM  Allergan (AGN) Down 8.3% Since Earnings Report: Can It Rebound? Zacks
Sep-01-17 07:09PM  Cramer's biggest investing mistakes CNBC Videos
06:44PM  Cramer admits his biggest investing mistakes CNBC
07:57AM  Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update Zacks
Aug-30-17 10:01AM  Gilead-Kite: A New Transformative Deal For Biotech Forbes
Aug-29-17 10:23AM  Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic InvestorPlace
Aug-28-17 10:50PM  ALLERGAN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) Business Wire
04:15PM  Allergan Announces Settlement of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with Famy Care PR Newswire
08:00AM  The Allergan Foundation to Donate $100,000 to Support Hurricane Harvey Relief Efforts PR Newswire
Aug-25-17 10:50PM  ALLERGAN 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Allergan, Inc. - (AGN) Business Wire
08:00AM  Allergan to Present at the 2017 Morgan Stanley Global Healthcare Conference PR Newswire
Aug-24-17 10:03PM  3 Top Healthcare Stocks to Buy Now Motley Fool
Aug-23-17 09:07AM  Key Developments for Allergan in 2Q17 Market Realist
08:31AM  The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins Zacks
08:30AM  Allergan Teams Up With Comedian Vanessa Bayer and OB/GYN Jessica Shepherd, M.D., M.B.A, to Debut the Know Your Birth Control Campaign PR Newswire
07:37AM  How Allergans International Segment Performed in 2Q17 Market Realist
Aug-22-17 10:50PM  ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) GlobeNewswire
05:15PM  Top Analyst Reports for Allergan, Ecolab & Exelon Zacks
01:25PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. - AGN PR Newswire
10:36AM  How Did Allergans US General Medicines Segment Perform in 2Q17? Market Realist
07:37AM  How Allergans Segments Contributed to Overall Revenues Market Realist
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOJun 16Buy235.964410,327131,178Sep 18 08:49 PM
Basgoz NesliDirectorMay 18Option Exercise84.441,889159,5077,919May 22 04:26 PM
Basgoz NesliDirectorMay 18Sale220.451,889416,4306,030May 22 04:26 PM
GALLAGHER MICHAEL RDirectorMay 04Option Exercise245.2517,6934,339,20820,272May 05 06:34 PM
SAUNDERS BRENT LChairman, President and CEOMar 29Buy242.214310,299131,135Sep 18 08:49 PM
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E51.88 EPS (ttm)2.88 Insider Own0.10% Shs Outstand494.87M Perf Week-3.65%
Market Cap73.88B Forward P/E29.30 EPS next Y5.10 Insider Trans-20.92% Shs Float491.47M Perf Month-1.94%
Income1.44B PEG1.89 EPS next Q1.01 Inst Own89.90% Short Float0.94% Perf Quarter3.90%
Sales6.53B P/S11.32 EPS this Y86.70% Inst Trans0.03% Short Ratio2.33 Perf Half Y17.68%
Book/sh15.79 P/B9.46 EPS next Y25.46% ROA11.20% Target Price161.20 Perf Year38.52%
Cash/sh9.98 P/C14.96 EPS next 5Y27.40% ROE19.20% 52W Range98.00 - 157.89 Perf YTD45.02%
Dividend- P/FCF30.80 EPS past 5Y7.00% ROI13.20% 52W High-5.95% Beta1.00
Dividend %- Quick Ratio2.00 Sales past 5Y6.80% Gross Margin86.30% 52W Low51.53% ATR2.42
Employees15706 Current Ratio2.00 Sales Q/Q26.70% Oper. Margin27.80% RSI (14)37.22 Volatility1.48% 1.28%
OptionableYes Debt/Eq0.24 EPS Q/Q54.70% Profit Margin22.10% Rel Volume1.46 Prev Close149.30
ShortableYes LT Debt/Eq0.24 EarningsSep 19 AMC Payout0.00% Avg Volume1.99M Price148.50
Recom1.90 SMA20-3.55% SMA50-1.35% SMA20012.91% Volume2,913,178 Change-0.54%
Sep-06-17Initiated MoffettNathanson Buy
Aug-25-17Initiated Jefferies Buy $175
Jun-21-17Reiterated BMO Capital Markets Outperform $160 → $165
Jun-12-17Downgrade Pivotal Research Group Hold → Sell $109 → $112
Jun-09-17Reiterated BMO Capital Markets Outperform $140 → $160
May-25-17Reiterated RBC Capital Mkts Outperform $135 → $157
Apr-13-17Initiated Guggenheim Buy
Apr-12-17Initiated Stifel Buy $150
Mar-24-17Upgrade Credit Suisse Neutral → Outperform
Mar-17-17Upgrade Wunderlich Hold → Buy
Mar-17-17Reiterated RBC Capital Mkts Outperform $130 → $135
Mar-17-17Reiterated Pivotal Research Group Hold $104 → $109
Mar-17-17Reiterated BMO Capital Markets Outperform $125 → $140
Feb-28-17Resumed Robert W. Baird Outperform $125 → $130
Feb-08-17Reiterated RBC Capital Mkts Outperform $115 → $125
Jan-12-17Downgrade Pivotal Research Group Buy → Hold $136 → $104
Jan-11-17Initiated Wells Fargo Market Perform
Jan-05-17Initiated BMO Capital Markets Outperform $125
Nov-03-16Reiterated Wunderlich Hold $99 → $115
Sep-21-16Reiterated RBC Capital Mkts Outperform $115 → $116
Sep-22-17 12:06PM  Cheap Stocks In The Software/IT Services Sector Barrons.com
11:37AM  Adobe Systems, Inc. Value Analysis (NASDAQ:ADBE) : September 22, 2017 Capital Cube
08:07AM  Dow, S&P 500, Nasdaq Split As Apple Falls, Oil Rises, Fed Stays Hawkish: Week In Review Investor's Business Daily
Sep-21-17 11:27AM  Adobe Systems Incorporated (ADBE) Stock Dips Are Opportunities Go Long! InvestorPlace
10:41AM  Adobe Systems, Inc. breached its 50 day moving average in a Bearish Manner : ADBE-US : September 21, 2017 Capital Cube
08:05AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
12:44AM  [$$] Adobes Cloud Hits First Headwind The Wall Street Journal
Sep-20-17 03:05PM  Stocks In Negative Territory as Chances for December Hike Surge TheStreet.com
02:02PM  Adobe Systems Delivers 3rd-Quarter Figures GuruFocus.com
01:57PM  Wall Street Weighs In On Adobe's Mixed Earnings Report Benzinga
01:12PM  Adobe Is a Horse -- Jim Cramer Explains Why TheStreet.com
12:34PM  [$$] Adobe's Cloud Hits First Headwind The Wall Street Journal
12:02PM  Adobe Slips: This Is Just a Speed Bump, Say Bulls Barrons.com
11:43AM  Adobe Stock Dinged By Marketing Software Bookings Miss Investor's Business Daily
11:11AM  Stocks Fall To Session Lows As Apple Undercuts Key Support Levels Investor's Business Daily
10:41AM  The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux TheStreet.com
10:05AM  Adobe's Cloud Services Boost Revenues Across Divisions Yet Again Forbes
10:04AM  Adobe share slip but Canaccord Genuity analyst says fundamentals are strong MarketWatch
09:39AM  Investors Await Fed Move; Amazon To Link Alexa, Smart Glasses Investor's Business Daily
09:07AM  Analyst: Buy The Adobe Dip, Despite Q3 Bookings 'Blip' Benzinga
08:44AM  Stock Futures Trade Flat as Balance Sheet Decision From Fed Is Awaited TheStreet.com
08:29AM  Adobe (ADBE) Beats Earnings and Revenue Estimates in Q3 Zacks
07:52AM  Early movers: FDX, WMT, AMZN, BBB, PFE, LB & more CNBC
07:21AM  3 Stocks to Watch on Wednesday: Adobe Systems Incorporated (ADBE), Bed Bath & Beyond Inc (BBBY) and FedEx Corporation (FDX) InvestorPlace
05:45AM  Edited Transcript of ADBE earnings conference call or presentation 19-Sep-17 9:00pm GMT Thomson Reuters StreetEvents
Sep-19-17 09:16PM  Adobe beats Street 3Q forecasts Associated Press
08:10PM  Adobe Systems Beats Expectations (Again) on Cloud Strength Motley Fool
05:02PM  Adobe Slips: FYQ3 Beats, Q4 Revenue View In-Line Barrons.com
04:38PM  Adobe Systems Beats Third-Quarter Sales, Earnings Targets Investor's Business Daily
04:34PM  Adobe revenue beats on subscriber additions Reuters
04:29PM  Adobe Systems Inc. Earnings Beat But Look Closer at ADBE InvestorPlace
04:27PM  Stocks Edge Higher; Adobe Falls After Hours Following Earnings Investor's Business Daily
04:19PM  Adobe results top Street view, shares slip MarketWatch
04:13PM  Adobe reports 25.8 percent rise in quarterly revenue Reuters
04:07PM  Adobe Systems beats the Street CNBC Videos
04:05PM  Adobe Reports Record Revenue Business Wire
11:51AM  Adobe Reports Earnings Amidst Strong Momentum, Here's How To Protect Gains Forbes
10:43AM  Bartosiak: Trading Adobe's (ADBE) Earnings with Options Zacks
10:00AM  Adobe Systems May Be Ready for a Breather After Strong Run TheStreet.com
Sep-18-17 04:10PM  Adobe, FedEx To Report; 5 Logistics Stocks To Watch: Investing Action Plan Investor's Business Daily
02:13PM  Adobe's Cloud Services To Continue To Drive Revenue Growth Forbes
10:09AM  Oracle, FedEx, UPS, Adobe and General Mills are part of Zacks Earnings Preview Zacks
09:51AM  NVIDIA, Avon Products, Adobe Systems, FedEx and Finish Line highlighted as Zacks Bull and Bear of the Day Zacks
Sep-15-17 04:58PM  Q3 Earnings Season Gets Underway Zacks
04:15PM  Adobe Sales, Earnings Growth Seen Slowing, But Still Healthy Investor's Business Daily
04:07PM  Fed, Adobe, FedEx, Defense Giants Lead Weekly Investing Action Plan Investor's Business Daily
04:04PM  Upcoming Earnings Reports to Watch: ADBE, FDX, FINL Zacks
11:11AM  The Zacks Analyst Blog Highlights: Raytheon, Simon Property Group, Anthem, Adobe and Travelers Zacks
06:59AM  Will Stiff Competition Hit Adobe Systems' (ADBE) Q3 Earnings? (Revised) Zacks
Sep-14-17 08:30PM  Hate Risk? You'll Love These 3 Stocks Motley Fool
04:57PM  Top Stock Reports for Raytheon, Simon Property Group & Anthem Zacks
01:00PM  Adobe to Webcast Q3 FY2017 Earnings Conference Call Business Wire
09:25AM  Adobe Systems (ADBE) Set to Top Estimates in Q3 Earnings Zacks
05:45AM  Apple Inc. (AAPL) Stock Edges Toward Trillion-Dollar Market Cap InvestorPlace
Sep-13-17 04:06PM  Adobe Breaks New Ground in Video at IBC 2017 Business Wire
10:59AM  Adobe to Offer Digital Marketing in Web Connected Vehicles Zacks
Sep-12-17 08:08AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Sep-11-17 05:07PM  How Adobe wants to help advertisers reach you in your car American City Business Journals
11:53AM  Why Software Stocks Can Keep Climbing Barrons.com
10:12AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
09:00AM  Adobe Wants to Bring Digital Marketing to Your Car Bloomberg
08:29AM  Adobe's CIO Is The Company's First Customer And A Cloud Champion Forbes
08:00AM  Why Mutual Fund Managers Are Betting On Tech, 'Quality' Stocks Investor's Business Daily
Sep-09-17 04:15PM  14 Stocks Insulated From Amazon's Dominance Benzinga
Sep-08-17 10:26AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
03:00AM  Microsoft Hits 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Sep-07-17 02:00PM  Media Alert: Adobe Poised to Achieve Pay Parity in U.S. and India Business Wire
09:00AM  Adobe and Microsoft expand strategic partnership to drive e-signatures and collaboration among teams in the cloud PR Newswire
Sep-06-17 05:36PM  Prices Keep Falling Faster Online. But for How Long? Bloomberg
01:49PM  Analyst Picks: 2 Software Stocks to Buy, 1 to Hold Motley Fool
Sep-01-17 08:07AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-31-17 04:07PM  Adobe Looks Pretty Solid Here TheStreet.com
08:07AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-29-17 10:22AM  Adobe Sensei Transforms Brand Emails Through Design and Intelligence Business Wire
08:07AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-28-17 11:00AM  2017 Adobe Design Achievement Awards Winners Announced Business Wire
Aug-25-17 10:51AM  VMware Has Hit A 'Tipping Point,' Analyst Upgrades Benzinga
08:06AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-22-17 12:09PM  3 Big Stock Charts for Tuesday: Adobe Systems Incorporated (ADBE), Caterpillar Inc. (CAT) and Zoes Kitchen Inc (ZOES) InvestorPlace
08:06AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-17-17 11:49PM  Asian shares slide as Wall Street fall, Spain attack weigh Associated Press
11:26AM  The Zacks Analyst Blog Highlights: Apple, Salesforce, Adobe Systems, AppFolio and Take-Two Interactive Zacks
12:10AM  Nasdaq Adds 8th Distribution Day: May The Odds Always Be In Your Favor Investor's Business Daily
Aug-16-17 04:32PM  5 Tech Stocks That Just Hit All-Time Highs Zacks
11:27AM  How Microsoft and Other Software Giants Are Growing in a Cloud-Focused World TheStreet.com
08:55AM  Adobe Systems (ADBE) Scales a New 52-Week High of $150.65 Zacks
Aug-15-17 11:32PM  VMware, Microsoft and Other Software Giants Are Growing in a Cloud-Heavy World TheStreet.com
06:00AM  If bitcoin were a stock, here's where it'd rank on the S&P 500 CNBC
Aug-14-17 01:13PM  Moody's assigns Baa2 rating to VMware's senior unsecured note issuance Moody's
Aug-12-17 08:07AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
01:55AM  Edited Transcript of ADBE earnings conference call or presentation 20-Jun-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 08:06AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-10-17 10:42AM  The Zacks Analyst Blog Highlights: Adobe Systems, Five9, Red Hat and Amazon Zacks
10:35AM  Video: Adobe just open sourced their Common Control Framework-here's how your company can benefit from it Tech Republic
08:07AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-09-17 04:28PM  3 Cloud Stocks to Buy Right Now Zacks
02:56PM  What Is Cloaking and Why Is Facebook So Upset About It? Fortune
08:07AM  See what the IHS Markit Score report has to say about Adobe Systems Inc. Markit
Aug-08-17 08:32AM  The Long-Term Trend That Makes Adobe Systems Incorporated an Awesome Buy Motley Fool
Aug-07-17 10:09AM  The boom in customer data needs to find its way into more CFO offices CNBC
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, advertising and media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lewnes AnnEVP, Chief Marketing OfficerSep 13Sale155.881,953304,43456,356Sep 14 05:01 PM
Lewnes AnnEVP, Chief Marketing OfficerAug 09Sale146.681,953286,46658,309Aug 09 07:05 PM
Parasnis AbhayEVP & CTOJul 21Sale149.3812,5001,867,20512,623Jul 21 04:55 PM
Parasnis AbhayEVP & CTOJul 20Option Exercise0.0041,750046,908Jul 21 04:55 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJul 20Sale150.0010,0001,500,00065,083Jul 21 04:57 PM
GESCHKE CHARLES MDirectorJul 13Sale145.1625,0003,628,985172,024Jul 14 04:40 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 12Sale144.001,953281,23259,991Jul 14 04:17 PM
ROSENSWEIG DANIELDirectorJun 28Sale143.284,000573,1242,268Jun 30 04:40 PM
ROSENSWEIG DANIELDirectorJun 28Sale143.957,0001,007,6528,801Jun 30 04:40 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJun 23Sale145.005,000725,00074,812Jun 27 05:13 PM
WARNOCK JOHN EDirectorJun 22Sale144.0732,6004,696,796487,301Jun 23 04:08 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 14Sale139.292,233311,03561,944Jun 15 06:02 PM
Lewnes AnnEVP, Chief Marketing OfficerMay 10Sale135.862,233303,37564,177May 11 06:27 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 12Sale129.962,233290,20166,410Apr 13 04:17 PM
Desmond LauraDirectorApr 11Option Exercise0.002,801023,852Apr 13 04:14 PM
GESCHKE CHARLES MDirectorApr 11Option Exercise0.002,8010172,024Apr 13 04:15 PM
ROSENSWEIG DANIELDirectorApr 11Option Exercise0.002,801015,801Apr 13 04:15 PM
BARNHOLT EDWARD WDirectorApr 11Option Exercise0.002,801035,925Apr 13 04:13 PM
BURGESS ROBERT KDirectorApr 11Option Exercise0.002,801039,925Apr 13 04:13 PM
CALDERONI FRANKDirectorApr 11Option Exercise0.002,801023,852Apr 13 04:14 PM
DALEY JAMES EDirectorApr 11Option Exercise0.002,801030,887Apr 13 04:14 PM
Banse AmyDirectorApr 11Option Exercise0.002,801030,592Apr 13 04:12 PM
LAMKIN BRYANEVP & GM, Digital MediaMar 31Sale130.3020,0002,605,95052,083Mar 31 07:29 PM
Lewnes AnnEVP, Chief Marketing OfficerMar 22Sale125.002,233279,12568,643Mar 24 04:05 PM
GESCHKE CHARLES MDirectorMar 20Sale125.9559,5507,500,060169,223Mar 21 04:25 PM
LAMKIN BRYANEVP & GM, Digital MediaMar 15Option Exercise0.0019,750082,388Mar 17 04:27 PM
GARRETT MARKEVP, CFO & Asst. SecretaryFeb 06Sale114.1245,1995,158,0864,339Feb 07 04:10 PM
BURGESS ROBERT KDirectorFeb 02Option Exercise42.6125,0001,065,25062,124Feb 03 04:11 PM
BURGESS ROBERT KDirectorFeb 02Sale113.1925,0002,829,71037,124Feb 03 04:11 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 27Sale113.0810,4401,180,54447,482Jan 27 04:14 PM
Rencher BradleyEVP & GM, Digital MarketingJan 25Sale113.9640,0004,558,27650,735Jan 26 04:14 PM
NARAYEN SHANTANUPresident and CEOJan 25Sale113.91173,70319,787,246299,243Jan 26 04:13 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 25Sale113.7855,0006,257,92851,919Jan 26 04:14 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00113,7560131,387Jan 26 04:14 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0080,153078,016Jan 26 04:12 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0056,620080,588Jan 26 04:12 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0056,620089,524Jan 26 04:13 PM
NARAYEN SHANTANUPresident and CEOJan 24Option Exercise0.00363,2400549,812Jan 26 04:13 PM
Parasnis AbhayEVP & CTOJan 24Option Exercise0.008,16508,436Jan 26 04:13 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0056,036068,744Jan 26 04:12 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00103,587071,082Jan 26 04:12 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.0080,7200101,620Jan 26 04:14 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0013,748010,098Jan 26 04:14 PM
DALEY JAMES EDirectorJan 20Option Exercise33.2310,000332,30038,086Jan 23 04:58 PM
DALEY JAMES EDirectorJan 20Sale110.0210,0001,100,20028,086Jan 23 04:58 PM
WARNOCK JOHN ECo-Chairman of the BoardJan 17Sale107.285,000536,405559,600Jan 17 04:14 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 09Sale108.5223,1002,506,775228,773Jan 09 06:24 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 06Sale108.131,348145,7600Jan 06 06:54 PM
GESCHKE CHARLES MCo-Chairman of the BoardJan 04Sale104.0348,1005,003,800251,873Jan 05 04:20 PM
WARNOCK JOHN ECo-Chairman of the BoardDec 19Sale105.416,000632,472565,600Dec 21 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceOct 10Sale110.0010,0001,100,00054,279Oct 11 04:43 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryOct 10Sale109.6413,3311,461,57930,993Oct 11 04:41 PM
WARNOCK JOHN ECo-Chairman of the BoardSep 27Sale106.995,000534,950571,600Sep 27 04:49 PM
ROSENSWEIG DANIELDirectorSep 26Sale107.4213,0001,396,4266,268Sep 27 04:47 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E68.41 EPS (ttm)2.27 Insider Own0.10% Shs Outstand299.45M Perf Week-1.56%
Market Cap46.52B Forward P/E9.54 EPS next Y16.28 Insider Trans0.00% Shs Float299.45M Perf Month8.52%
Income703.70M PEG5.61 EPS next Q3.64 Inst Own20.30% Short Float0.51% Perf Quarter-11.18%
Sales14.58B P/S3.19 EPS this Y-65.50% Inst Trans-8.13% Short Ratio1.14 Perf Half Y-10.72%
Book/sh103.48 P/B1.50 EPS next Y9.04% ROA1.00% Target Price226.08 Perf Year-23.84%
Cash/sh- P/C- EPS next 5Y12.20% ROE2.30% 52W Range139.36 - 205.13 Perf YTD-8.82%
Dividend0.92 P/FCF- EPS past 5Y-12.80% ROI2.10% 52W High-24.39% Beta1.64
Dividend %0.59% Quick Ratio0.50 Sales past 5Y22.30% Gross Margin64.10% 52W Low11.29% ATR2.91
Employees23906 Current Ratio1.00 Sales Q/Q54.20% Oper. Margin8.40% RSI (14)47.65 Volatility1.78% 1.51%
OptionableYes Debt/Eq0.69 EPS Q/Q108.60% Profit Margin4.70% Rel Volume0.46 Prev Close155.36
ShortableYes LT Debt/Eq0.59 EarningsAug 03 BMO Payout13.20% Avg Volume1.34M Price155.09
Recom1.80 SMA200.97% SMA50-0.59% SMA200-8.30% Volume617,357 Change-0.17%
Aug-17-17Initiated Evercore ISI Outperform $196
Jun-16-17Initiated Cantor Fitzgerald Overweight $222
Jun-09-17Reiterated Jefferies Buy $239 → $216
Jun-01-17Downgrade Liberum Buy → Hold
May-26-17Downgrade Bernstein Outperform → Mkt Perform
May-19-17Downgrade HSBC Securities Hold → Reduce
Mar-09-17Initiated Liberum Buy
Dec-02-16Initiated Societe Generale Buy
Sep-26-16Downgrade HSBC Securities Buy → Hold
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Sep-21-17 09:50AM  Is Shire plc (SHPG) a Suitable Value Stock? Zacks
Sep-18-17 10:00AM  Neos Therapeutics ADHD Drug Adzenys Receives Approval in US Zacks
Sep-15-17 07:39AM  Whats Coopermans View on Shire? Market Realist
Sep-12-17 04:38PM  Top Research Reports for Disney, Kraft Heinz & CVS Health Zacks
Sep-08-17 09:53AM  Alnylam Shares Plunge on Patient Death, Dosing Suspended Zacks
Sep-07-17 01:03PM  Here's Why Shire PLC Stock Fell 10% in August Motley Fool
Sep-01-17 06:32AM  Shire plc : Total voting rights GlobeNewswire
Aug-30-17 07:20AM  Corporate News Blog - Sanofi Completes Acquisition of Vaccines Biotechnology Company, Protein Sciences ACCESSWIRE
Aug-24-17 10:08AM  Roche (RHHBY) Hemophilia A Drug Granted Priority Review Zacks
Aug-23-17 07:02AM  Shire plc : Director/PDMR Shareholding GlobeNewswire
05:33AM  Shire chief financial officer joins Boston ag-tech startup American City Business Journals
Aug-22-17 11:32AM  Shire plc : Director/PDMR Shareholding GlobeNewswire
Aug-21-17 01:29PM  UPDATE: Shire: There Goes the CFO! Barrons.com
09:01AM  Shire plc Director and Senior Management Changes GlobeNewswire
Aug-16-17 05:18PM  Shire Files Marketing Application for Lifitegrast in Europe Zacks
Aug-15-17 06:00AM  Shire applies for European approval of potential blockbuster eye drop American City Business Journals
04:55AM  Shire Gains as it Seeks European Approval For Dry Eye Treatment TheStreet.com
02:02AM  Shire announces submission of lifitegrast Marketing Authorization Application for treatment of dry eye disease in Europe GlobeNewswire
Aug-09-17 09:17AM  Shire plc : Director/PDMR Shareholding GlobeNewswire
Aug-04-17 09:47AM  Shire (SHPG) Beats on Q2 Earnings & Sales, Updates '17 View Zacks
02:52AM  Shire plc : Half-yearly report GlobeNewswire
Aug-03-17 02:29PM  Shire's ADHD Spinoff Idea Is Shaky Bloomberg
02:10PM  [$$] Lombard: Impatient Shire boss waits for market to catch up Financial Times
02:10PM  Shire Acq Inv Ireland Designated Activity Co -- Moody's: Shire's evaluation of neuroscience franchise credit negative Moody's
09:58AM  [$$] Shire Mulls Spinning-off or Selling Neuroscience Unit The Wall Street Journal
09:42AM  Shire tops Street 2Q forecasts Associated Press
07:53AM  Shire Surges on Baxalta Synergies and Strong Earnings Momentum TheStreet.com
07:10AM  Investor Network: Shire PLC to Host Earnings Call ACCESSWIRE
07:02AM  Shire plc : Shire reports strong Q2 2017 operating results and cash flow GlobeNewswire
Aug-01-17 07:02AM  Shire plc : Total voting rights GlobeNewswire
Jul-26-17 04:29PM  Shire Stock Rising on Takeover Talks TheStreet.com
07:01AM  Gap In Perceived and Actual Rates Of Prescription Stimulant Misuse, Abuse and Diversion Found Among College Students GlobeNewswire
Jul-20-17 11:08AM  New Strong Sell Stocks for July 20th Zacks
Jul-18-17 07:02AM  Shire plc : Notice of Results GlobeNewswire
07:02AM  Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement for Novimmune Bi-specific Antibody GlobeNewswire
Jul-16-17 08:18AM  [$$] Shire boss says share price at odds with drugs pipeline Financial Times
Jul-13-17 09:30AM  The Zacks Analyst Blog Highlights: Merck, Eli Lilly, Celgene, Gilead Sciences and Shire Zacks
08:13AM  5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings Zacks
Jul-12-17 06:01PM  A Cancer Breakthrough Near FDA Approval Has a Costly Side Effect Bloomberg
09:15AM  Analyst: Shire Shares Should Rebound, But Sustained Rally Unlikely Benzinga
Jul-11-17 08:39PM  Arena Pharma's Stock Could Still Double Even After Tuesday's Epic Run TheStreet.com
04:19PM  Alnylam (ALNY) Stock Down Despite Positive Hemophilia Data Zacks
Jul-10-17 09:47AM  Shire, Roche slug it out in billion-dollar haemophilia drug battle Reuters
Jul-07-17 09:42AM  Shire Completes NDA Filing for Hemophilia Drug with FDA Zacks
Jul-06-17 07:01AM  Shire submits investigational New Drug Application to FDA for Gene Therapy candidate SHP654 for treatment of Hemophilia A GlobeNewswire
02:02AM  Shire plc : Additional Listing GlobeNewswire
Jul-05-17 08:03AM  3 Reasons Sizzling-Hot Bioverativ Stock Can Go Even Higher Motley Fool
Jul-03-17 08:32AM  Shire plc : Director/PDMR Shareholding GlobeNewswire
07:01AM  Shire plc : Total voting rights GlobeNewswire
Jun-26-17 09:30AM  The Zacks Analyst Blog Highlights: Novartis, Roche, Shire, Neos and Novo Nordisk Zacks
Jun-23-17 08:02AM  SHIRE TO PRESENT NEW DATA AT ISTH 2017 TO ADVANCE THE STANDARD OF CARE IN HEMOPHILIA GlobeNewswire
07:42AM  Pharma Stock Roundup: NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod Zacks
Jun-22-17 10:54AM  Shire (SHPG) Receives MAA Validation for Veyvondi by EMA Zacks
09:36AM  Biotech Movers: Shire, Bellicum, Organovo TheStreet.com
01:00AM  Shire Announces EMA Validation of Veyvondi Marketing Authorization Application for Treatment of Von Willebrand Disease PR Newswire
Jun-21-17 10:52AM  Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US Zacks
10:25AM  Shire wins FDA approval for new ADHD drug American City Business Journals
Jun-20-17 07:19PM  Shire's long-acting ADHD drug wins U.S. approval Reuters
06:48PM  Shire plc: U.S. FDA Approves Mydayis (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older PR Newswire
Jun-19-17 09:45AM  Could Shire PLC (SHPG) Be a Great Stock for Value Investors? Zacks
09:02AM  Do You Really Want to Love Your Medicines? Fortune
Jun-16-17 10:54AM  Valeant: Stop Looking in the Rearview Mirror! Barrons.com
Jun-14-17 06:00AM  10 High-Quality Foreign-Stock Bargains Morningstar
Jun-08-17 10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Shire plc (SHPG) PR Newswire
Jun-07-17 03:53PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shire plc - SHPG PR Newswire
Jun-06-17 12:03PM  Down 24.6%, is BioCryst Pharmaceuticals Stock Now a Buy? Motley Fool
Jun-05-17 07:47AM  Key FDA Events to Watch Out for in Jun 2017 Zacks
May-30-17 12:13PM  Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1 Investopedia
May-25-17 03:06PM  Why BioCryst Pharmaceuticals Stock Caught Fire Today Motley Fool
07:00AM  Shire to Participate at the Jefferies Healthcare Conference PR Newswire
May-24-17 09:17AM  Ultragenyx Receives Priority Review for rhGUS from FDA Zacks
May-22-17 01:05PM  Shire and tiny Lexington biotech say hemophilia drug trial misses mark American City Business Journals
May-19-17 05:21PM  Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug Zacks
12:48PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
10:17AM  Company News for May 19, 2017 Zacks
08:15AM  Blog Coverage: Shire's Stock Price Jumped on Positive Results in Hereditary Angioedema Treatment Accesswire
07:43AM  Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More Zacks
01:00AM  Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of Endocrinology PR Newswire
May-18-17 05:27PM  Drugmaker Leads Industry Gains Thursday On Rare Disease Trial Investor's Business Daily
05:11PM  [$$] Biotech Investor Clarus Ventures Raising $880 Million Fund The Wall Street Journal
11:54AM  Shire's swelling disorder drug moves closer to U.S. approval Reuters
11:15AM  Shire gains $2B in market cap as rare disease drug aces late-stage trial American City Business Journals
09:00AM  The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis PR Newswire
07:18AM  Shire ADRs jump almost 7% premarket after positive trial of Angioedema treatment MarketWatch
07:00AM  Shire's Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by 87% Versus Placebo in Phase 3 26-week Pivotal Trial PR Newswire
May-16-17 04:55PM  [$$] Health-Care Investor Agent Capital Seeks $100 Million Fund The Wall Street Journal
07:00AM  Shire Continues 20-Year Commitment to ADHD with New Research at 2017 Annual Meeting of American Psychiatric Association PR Newswire
May-15-17 04:37PM  ETFs with exposure to Shire Plc : May 15, 2017 Capital Cube
May-05-17 04:33PM  ETFs with exposure to Shire Plc : May 5, 2017 Capital Cube
10:37AM  Keryx (KERX) Q1 Loss Wider than Expected, Revenues Beat Zacks
May-04-17 11:10AM  Shire Plc :SHPG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017 Capital Cube
May-03-17 11:17AM  Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View Zacks
10:32AM  Momenta (MNTA) Q1 Loss Narrower than Expected, Sales Beat Zacks
May-02-17 09:23AM  [$$] Shire Profit Pressured by Baxalta Takeover Costs The Wall Street Journal
09:10AM  Durham CEO on deal with Shire valued at up to $535M American City Business Journals
08:42AM  Shire Stock Lifted By First-Quarter Earnings Beat TheStreet.com
07:27AM  Shire tops Street 1Q forecasts Associated Press
07:00AM  Shire Delivers Strong Q1 2017 Revenue Growth While Advancing Late-stage Pipeline PR Newswire
May-01-17 07:00AM  Shire and Parion Sciences Enter into a Collaborative License Agreement to Advance P-321 for Ophthalmic Indications PR Newswire
Apr-26-17 01:00AM  Shire Granted EU Conditional Marketing Authorisation for Natpar (Parathyroid Hormone) for the Treatment of Patients with Chronic Hypoparathyroidism PR Newswire
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), including VYVANSE/VENVANSE, a pro-drug stimulant; ELVANSE/TYVENSE; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist for oral symptomatic treatment of chronic constipation in women. In addition, it offers FOSRENOL, a phosphate binder for use in end-stage renal disease receiving dialysis; and XAGRID for the reduction of elevated platelet counts in at-risk essential thrombocythemia patients, as well as for the treatment of thrombocythemia. Further, the company provides REPLAGAL for the treatment of Fabry disease; ELAPRASE for the treatment of hunter syndrome; VPRIV for the treatment of type 1 Gaucher disease; and FIRAZYR for the symptomatic treatment of acute attacks of hereditary angioedema. Additionally, it offers FOSRENOL for the treatment of hyperphosphatemia in end stage renal disease; XAGRID for the reduction of elevated platelet counts; and CINRYZE, a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema. The company also licenses its patented antiviral products for human immunodeficiency virus and hepatitis B virus. Shire plc markets its products directly to government hospitals, clinics, pharmacies, and other agencies; and through wholesalers and distributors. The company sells its products in North America, the United Kingdom, the Republic of Ireland, and internationally. Shire plc has research collaboration with Santaris Pharma A/S. The company was founded in 1986 and is headquartered in Dublin, Ireland.
DAL Delta Air Lines, Inc. daily Stock Chart
DAL [NYSE]
Delta Air Lines, Inc.
IndexS&P 500 P/E9.56 EPS (ttm)5.04 Insider Own0.10% Shs Outstand736.35M Perf Week-0.23%
Market Cap35.46B Forward P/E8.25 EPS next Y5.84 Insider Trans-13.52% Shs Float728.80M Perf Month2.14%
Income3.71B PEG1.29 EPS next Q1.66 Inst Own88.10% Short Float2.34% Perf Quarter-8.81%
Sales39.88B P/S0.89 EPS this Y2.90% Inst Trans-0.29% Short Ratio2.17 Perf Half Y4.88%
Book/sh18.52 P/B2.60 EPS next Y10.92% ROA7.20% Target Price- Perf Year26.57%
Cash/sh4.06 P/C11.87 EPS next 5Y7.42% ROE29.00% 52W Range37.91 - 55.75 Perf YTD-2.09%
Dividend1.22 P/FCF11.94 EPS past 5Y41.80% ROI23.90% 52W High-13.06% Beta1.25
Dividend %2.53% Quick Ratio0.40 Sales past 5Y2.50% Gross Margin53.60% 52W Low27.86% ATR1.01
Employees87263 Current Ratio0.40 Sales Q/Q3.30% Oper. Margin15.20% RSI (14)51.74 Volatility1.78% 2.19%
OptionableYes Debt/Eq0.67 EPS Q/Q-17.40% Profit Margin9.30% Rel Volume0.58 Prev Close48.16
ShortableYes LT Debt/Eq0.59 EarningsOct 12 BMO Payout16.00% Avg Volume7.87M Price48.47
Recom- SMA202.02% SMA50-1.79% SMA200-1.76% Volume4,587,896 Change0.64%